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ABSTRACT OF THE DISSERTATION 
PREDICTORS OF CERVICAL CANCER SCREENING AND PHYSICIAN 
RECOMMENDATIONS AMONG WOMEN IN THE UNITED STATES USING 
CURRENT SCREENING GUIDELINES 
by 
Vincy Samuel 
Florida International University, 2018 
Miami, Florida 
Professor Nasar U. Ahmed, Major Professor 
In 2015, there were 257,524 women with cervical cancer (CC) in the United 
States (U.S.).  CC is preventable; screening detects early-stage cancer when treatment is 
most successful.  This study aimed to identify predictors for CC screening adherence 
among U.S. women, describe predictors for screening adherence by marital status, and 
examine physician recommendation for CC screening and adherence to those 
recommendations.  Predictors were grouped as demographic, acculturation, access to 
care, chronic conditions, and health behaviors.  Descriptive analyses were performed on a 
sample of 10,667 women from the 2015 National Health Interview Survey, and multiple 
logistic regression models determined predictors of CC screening adherence, physician 
recommendations, and adherence to physician recommendations.   
Overall, 81.7% (95%CI=80.7-82.7%) of U.S. women adhered to CC screening 
guidelines.  Adherence declined with increasing age after 39 years old.  Never married 
women (adjusted odds ratio[aOR]=0.67, CI=0.56-0.79) or current smokers (aOR=0.70,  
  
v 
 
CI=0.59-0.84) had lower odds, while college-educated women had greater odds 
(aOR=1.38, CI=1.14-1.67) of CC screening adherence.  
Among unmarried women, 78.6% adhered to CC screening.  Unmarried women 
who were unemployed (aOR=0.48, CI=0.38-0.62), had no physician visits (aOR=0.58, 
CI=0.40-0.85), no usual source of care (aOR=0.67, CI=0.50-0.89), never heard of HPV 
(aOR=0.59, CI=0.46-0.76), never received HPV vaccine (aOR=0.50, CI=0.34-0.75), no 
birth control use (aOR=0.33, CI=0.23-0.47), no flu shot (aOR=0.62, CI=0.48-0.80), and 
perceived low breast cancer risk (aOR=0.66, CI=0.47-0.92) had lower odds of adherence.   
Among women with a physician, 55.6% received screening recommendations.  
Race/ethnicity, access to care, HPV knowledge and vaccine receipt, age when first child 
was born, and flu shot were significant predictors of physician recommendation for CC 
screening.  Significant predictors of adherence to physician recommendation included 
education, employment, English proficiency, outpatient clinic visits, usual source of care, 
age when first child was born, birth control, alcohol use, smoking status, flu shot, and 
health status.   
Based on our results, two levels of intervention should be explored.  First, 
targeted interventions are needed for women who are unmarried, have low socio-
economic status, and limited access to care to reduce cervical cancer risk.  Second, 
interventions for physicians to increase screening recommendations to all eligible women 
are needed to improve national screening rates.   
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CHAPTER I. 
INTRODUCTION 
Overview 
Epidemiology of cervical cancer 
Cervical cancer is one of the most preventable cancers. This cancer is the fourth 
most common cancer among women worldwide, and among the top causes of cancer 
death.  Approximately 85% of cervical cancer cases occur in less-developed regions 
(International Agency for Research on Cancer, 2016).  Previously one of the most 
common cancers among women in the United States, cervical cancer now ranks number 
21 among common types of cancer, with cervical cancer representing only 0.8% of all 
new cancer cases (National Cancer Institute [NCI], n.d.).  
  In the United States from 2009 to 2013, the incidence rate of cervical cancer was 
7.5 per 100,000 women per year, and the mortality rate was 2.3 per 100,000 women.  The 
lifetime risk of developing cervical cancer was 0.6 percent of women (NCI, n.d.).  
Hispanic women had the highest incidence of cervical cancer, followed by non-Hispanic 
Black, White, American Indian/Alaska Native, and Asian/Pacific Islander women.  Non-
Hispanic Black women had the highest mortality rate, followed by Hispanic, Asian/P 
etacific Islander, non-Hispanic White, and American Indian/Alaska Native women 
(Centers for Disease Control and Prevention [CDC], 2015). 
Cervical cancer rates also vary by state.  In 2012, Arizona, Arkansas, District of 
Columbia, Florida, Kentucky, Louisiana, Mississippi, Missouri, Tennessee, Texas, and 
Wisconsin had the highest incidence rates (8.2 to 9.6 per 100,000).   Alabama, Arkansas, 
District of Columbia, Florida, Georgia, Mississippi, Oklahoma, Texas, and West Virginia 
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had the highest mortality rates (2.8 to 5.3 per 100,000) (CDC, 2014).  Variations in 
incidence and mortality rates by state may be attributed to differences among racial and 
ethnic populations, differences in populations and health behaviors, differences in 
medical care, and the influence of aging (U.S. Department of Health and Human 
Services, 2018). 
In 2010, the annualized mean net cost of care for cervical cancer in women under 
65 years of age was $54,209 in the initial year after diagnosis and $1,425 between the 
initial year and the last year of life (Mariotto, Yabroff, Shao, Feuer, & Brown, 2011).  
Most private insurance companies, public employee health plans, and Medicaid offer 
coverage and reimbursement for Pap testing (American Cancer Society [ACS], 2016).  
For women without insurance, programs such as the National Breast and Cervical Cancer 
Early Detection Program provide access to cervical cancer screening and diagnostic 
testing for low-income, uninsured, and underserved women (CDC, 2016). 
The risk of cervical cancer increases with smoking, positive HIV status, use of 
oral contraceptives for five or more years, giving birth to three or more children, and 
having multiple sex partners (CDC, 2015).  Cervical cancer is the most common type of 
human papillomavirus (HPV)- related cancer, and almost all cervical cancers are caused 
by HPV.  HPV infections may clear on its own, but some infections persist and cause 
cellular changes, which can lead to genital warts or cancers (NCI, 2015). 
       
Prevention 
Most cervical cancer cases could be prevented by primary prevention with the 
HPV vaccination, which is recommended for preteens at 11 to 12 years of age in order to 
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protect them from being exposed to HPV.  The HPV vaccine is recommended for men 
and women who did not receive or finish the HPV vaccine series until they reach the ages 
21 and 26, respectively (CDC, 2015).  In 2014, 40.2% of women and 8.2% of men 19 to 
26 years of age reported receiving at least one dose of the HPV vaccine (CDC, 2016).  
Therefore, there is still a large part of the population that has not been fully vaccinated 
with the HPV vaccine. 
Cervical cancer is highly preventable when screening and follow-up 
recommendations are adhered to (CDC, 2015).  Up to 93% of cervical cancer cases can 
be prevented through screening and HPV vaccination (CDC, 2014).  If cervical cancer is 
diagnosed at an early stage, it is treatable and associated with long term survival (CDC, 
2015).  Cervical cancer is a slow-growing cancer (National Cervical Cancer Coalition 
[NCCC], 2016).   
Secondary prevention through cervical cancer screening identifies cervical 
abnormalities.  Cervical cancer cases and deaths have decreased over the last 40 years 
due to women receiving regular Pap tests (CDC, 2015).  However, from 2008 to 2010, 
cervical cancer screening rates declined slightly (Brown et al., 2014).  Additionally, the 
proportion of 18 year-old women who reported ever having a Pap test decreased from 
approximately 50% in 2000 to 38% in 2010 (Roland et al., 2013).  According to the U.S. 
Preventive Services Task Force, a Pap test is recommended for women between the ages 
of 21 and 65 years old who have not had a hysterectomy.  Recommendations regarding 
the frequency of cervical cancer screening have changed over the years (ACS, 2018).  
Since 2012, a Pap test is recommended every three years, as compared to more frequently 
in the years prior to 2012 (Table 1).  Cervical cancer screening is only recommended 
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every five years if a Pap test and an HPV test are conducted as part of a co-testing 
algorithm.  In 2018, the U.S. Preventive Services Task Force recommended screening 
with high risk HPV testing alone every five years.  These recommendations apply to 
women who have not received a diagnosis of a high-grade precancerous cervical lesion or 
cervical cancer, women without in utero exposure to diethylstilbestrol, or women who are 
HIV negative and not otherwise immunocompromised (U.S. Preventive Services Task 
Force [USPSTF], 2018). 
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Table 1:  History of recommendations for the early detection of cervical cancer in women 
without symptoms   
 
Dates Test Age Frequency 
Pre 
1980 
Pap test Not specified As part of a regular check-up 
1980 - 
1987 
Pap test 20 and over; under 20 if 
sexually active 
Yearly, but after 2 negative exams 1 year 
apart, at least every 3 years 
Pelvic 
exam 
20 – 39 Every 3 years 
40 and over Yearly 
1987 - 
2002 
Pap test 18 & over or sexually 
active 
Yearly, but after 3 consecutive normal 
exams, less frequently at the discretion of 
the doctor 
Pelvic 
exam 
18 & over or sexually 
active 
Yearly 
2003 - 
2012 
Pap test Start 3 years after first 
vaginal intercourse but 
no later than 21 
Yearly with conventional Pap test or every 
2 years with liquid-based Pap test 
30 and over After 3 normal results in a row, screening 
can be every 2 to 3 years. An alternative is 
a Pap test plus HPV DNA testing every 3 
years.* 
70 and over After 3 normal Pap tests in a row within the 
past 10 years, women may choose to stop 
screening** 
Pelvic 
exam 
Not specified Discuss with health care provider 
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2012 - 
2018
1
 
Pap test 21 - 29 Every 3 years* 
Pap test 
plus HPV 
DNA test 
30 - 65 Every 5 years* 
An alternative is screening with a Pap test 
alone every 3 years* 
Over 65 A woman should stop screening unless she 
had a serious cervical pre-cancer or cancer 
in the last 20 years 
2018 - 
Present 
Pap test 21 - 29 Every 3 years* 
Pap test plus 
HPV DNA 
test 
 
OR 
 
hrHPV test 
30 - 65 Every 5 years* 
An alternative is screening with a Pap test 
alone every 3 years* 
Over 65 A woman should stop screening unless she 
had a serious cervical pre-cancer or cancer 
in the last 20 years 
*Doctors may suggest a woman be screened more often if she has certain risk factors, 
such as a history of DES exposure, HIV infection, or a weak immune system 
**Women with a history of cervical cancer, DES (diethylstilbestrol) exposure, or who 
have a weak immune system should continue screening as long as they are in reasonably 
good health 
1
 These guidelines are not meant to apply to women who have been diagnosed with 
cervical cancer. These women should have follow-up testing as recommended by their 
healthcare team. 
 
Sources:  American Cancer Society (2018).  History of ACS recommendations for the 
early detection of cancer in people without symptoms.  Retrieved from 
https://www.cancer.org/health-care-professionals/american-cancer-society-prevention-
early-detection-guidelines/overview/chronological-history-of-acs-recommendations.html. 
 
U.S. Preventive Services Task Force (2018).  Final recommendation statement:  Cervical 
Cancer screening.  Retrieved from 
https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStateme
ntFinal/cervical-cancer-screening2. 
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The five-year observed survival rate decreases as the disease progresses.  The 
five-year survival rate is 93% at stage 0, 93% at stage IA, 80% at stage IB, 63% at stage 
IIA, 58% at IIB, 35% at stage IIIA, 32% at stage IIIB, 16% at IVA, and 15% at stage 
IVB.  These survival rates can be improved through adherence to follow-up care (ACS, 
2016). 
Cervical cancer screening provides the best chance of identifying the cancer at an 
early stage, which is when treatment will be most successful.  Prior to becoming cancer, 
abnormal cervix cell changes occur, which can also be identified through screening 
(ACS, 2014).  Additional tests such as repeat Pap test or co-test, HPV test, colposcopy, 
biopsy, endocervical sampling, and endometrial sampling may be performed, depending 
on age and initial Pap test results (American Congress of Obstetricians and 
Gynecologists, 2016).  Treatment during this pre-cancerous change can prevent it from 
becoming cervical cancer.  If the changes in cervical cells are moderate or high-grade, 
treatment such as loop electrosurgical excision procedure, cryotherapy, laser therapy, or 
conization may be indicated to prevent cancer.  If the pre-cancerous cell changes progress 
to cervical cancer, tertiary prevention through treatment of invasive cancer would be 
indicated (ACS, 2014).  Follow-up to any abnormal results will allow for appropriate 
diagnosis and subsequent treatment.  
 
Follow-Up 
Although screening is one of the most important elements in the reduction of 
cervical cancer incidence and mortality, timely follow-up care for abnormal lesions is just 
as important (Kaplan et al., 2000).  Every year in the United States, approximately two to 
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three million women learn that they have an abnormal Pap result (Hunt, 2002).  In order 
to sufficiently reduce the incidence and mortality of cervical cancer, an abnormal Pap test 
requires a follow-up visit, diagnosis, and treatment (Yabroff, Kerner, & Mandelblatt, 
2000).  Therefore, it is necessary to obtain a confirmatory follow-up Pap test if an 
abnormality is detected.  However, many women fail to obtain the necessary follow-up 
care (Eggleston, Coker, Prabhu, Cordray, & Luchok, 2007).  Women who do not receive 
the appropriate follow-up forfeit the benefits of early treatment (Melnikow, 1999).  A 
delay in follow-up visits increases the risk of developing cervical cancer or being 
diagnosed with an advanced stage of the disease.  If abnormalities are detected early 
enough and the necessary follow-up visits and treatment are adhered to, there is close to a 
100% survival rate.  Among women with invasive cervical carcinomas, 13% can be 
attributed to lack of follow-up after abnormal Pap results (Eggleston et al., 2007).  
Despite this, approximately 20% to 50% of women with abnormal Pap results do not 
comply with follow-up care.  Consequently, there are still many women who are being 
diagnosed with and even dying from a preventable disease (Kaplan et al., 2000). 
Factors associated with non-adherence to Pap screening guidelines include lack of 
a usual source of care and health insurance, income and educational status, obesity, 
smoking, immigrant status, and foreign birth (Nelson, Moser, Gaffey, & Waldron, 2009).  
Among women with an abnormal Pap smear, those perceived to have low literacy by 
their physician were more likely to not follow-up (Lindau, Basu, & Leitsch, 2006). 
 There is great variation in the rates of follow-up across different populations and 
settings.  Approximately 7% to 49% of women with abnormal results do not follow-up 
with the necessary diagnostic tests (Yabroff et al., 2000).  Characteristics associated with 
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women who do not follow-up after abnormal Pap tests are young age, low socioeconomic 
status, and minority classification.  Minority women have the lowest rates of completing 
a follow-up (Abercrombie, 2001).  Minority women with low income are the least likely 
to comply with follow-up care (Hunt, 2002).  About 80% of low-income women do not 
adhere to the recommended follow-up treatment (Engelstad et al., 2001).  Poverty is the 
most common factor for not following up after abnormal results (Saslow et al., 2007).  
Some barriers that these women may face when being told that they need a follow-up 
exam are their understanding of how abnormal results can affect them, their beliefs about 
their risk of having cancer, how much they believe that following up can potentially help 
to prevent cancer and improve their survival, and costs associated with follow-up care.  
Furthermore, some women may prefer not to hear that something may truly be wrong 
with them and may opt to not find out (Ell et al., 2002).  In a systematic literature review 
with the outcome as adherence to follow-up after an abnormal Pap test, African American 
women were not as likely to obtain the appropriate follow-up as compared to other 
ethnicities (Benard et al., 2005; Eggleston et al., 2007; Engelstad et al., 2005).  
Inconsistent evidence for associations between race, income, and age and screening has 
been found (Eggleston et al., 2007). 
 
Research aims and objectives 
Aim 1:  To describe predictors for cervical cancer screening adherence using current 
guidelines among a sample of nationally representative women. 
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Objective 1a:  Describe demographic, acculturation, access to health care, and  
health behavior and knowledge factors associated with cervical cancer screening 
adherence. 
Objective 1b:  Describe demographic, acculturation, access to health care, and 
health behavior and knowledge factors for cervical cancer screening adherence by 
race/ethnicity. 
 
Aim 2:  To assess the association of marital status with cervical cancer screening 
adherence using current guidelines among a sample of nationally representative women. 
Objective 2a:  Describe demographic, acculturation, access to health care, and 
health behavior and knowledge factors for cervical cancer screening adherence among 
married and unmarried women. 
Objective 2b:  Describe demographic, acculturation, access to health care, and 
health behavior and knowledge factors for cervical cancer screening adherence among 
unmarried women by race/ethnicity. 
 
Aim 3:  To explore the gap between physician recommendation of cervical cancer 
screening and adherence to physician recommendation.  
Objective 3a:  Explore demographic, acculturation, access to health care, and 
health behavior and knowledge predictors for physician recommendation. 
Objective 3b:  Explore demographic, acculturation, access to health care, and 
health behavior and knowledge predictors for adherence to physician recommendation. 
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Objective 3c:  Explore the reasons for not adhering to cervical cancer screening 
after physician recommendation. 
 
Public health significance 
 Many studies on cervical cancer screening focus on specific geographic regions or 
racial/ethnic groups (Hatcher, Studts, Dignan, Turner, & Schoenberg, 2011; Ji, Chen, 
Sun, & Liang, 2010; Miranda-Diaz, Betancourt, Ruiz-Candelaria, & Hunter-Mellado, 
2016; Paskett et al., 2010; Sadler et al., 2010; Schoenberg, Studts, Hatcher-Keller, Buelt, 
& Adams, 2013).  In addition, few studies use the most current screening guidelines in 
defining adherence (Watson, Benard, King, Crawford, & Saraiya, 2017; White et al., 
2017).  This study will add to the literature by using the most current screening guidelines 
to explore predictors for screening adherence and physician recommendation in a large 
nationally representative sample of women.  The results of this study can then be used in 
determining which populations to target to improve cervical cancer screening rates.    
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CHAPTER II. 
LITERATURE REVIEW 
 
Overview 
 The literature search for this study included a comprehensive review of scientific 
articles in English language from 2000 to 2017 in the following databases: MEDLINE, 
PubMed, and CINAHL.  Medical subject headings and keywords used included “cervical 
cancer”, “Pap”, “cervical cancer screening”, “marital status”, “unmarried”, “never 
married”, “physician recommendation”, “doctor recommended”, among others and from 
all years.  Reference lists of relevant articles were reviewed to identify additional articles. 
 
Predictors of cervical cancer screening 
Demographics 
Sociodemographic factors have been shown to be predictors of cervical cancer 
screening (Miles-Richardson, Allen, Claridy, Booker, & Gerbi, 2017).  In analyses of the 
2000 National Health Interview Survey, age, education attainment, and health insurance 
were associated with cervical cancer screening (Meissner, Yabroff, Dodd, Ballard-
Barbash, & Berrigan, 2009).  Low family income, low educational level, and being 
unmarried were associated with lower rates of Pap testing (Hewitt, Devesa, & Breen, 
2004).  Predictors for never having been screened for cervical cancer included Hispanic 
race, never being married, living below poverty level, fewer than 12 years of education, 
65 years of age or older, and unemployment.  Some of these predictors changed when 
analyzing those who had not been screened recently (Calle, Flanders, Thun, & Martin, 
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1993).  In addition, recent studies have shown that being non-Hispanic white reduced the 
likelihood of cervical cancer screening (Miles-Richardson et al., 2017). 
There are racial and ethnic differences in the association of these demographic 
factors with cervical cancer screening.  Hispanic and other race women were more likely 
(11.1% and 14.7%, respectively) to never have a Pap test than non-Hispanic white 
women (5.0%) or black women (5.8%) (Chen, Kessler, Mori, & Chauhan, 2012).  Among 
American Indian and Alaska Native women, higher educational level, income, presence 
of one or more chronic medical conditions, being 25 to 39 years of age, and having been 
ever married predicted Pap test use (Schumacher et al., 2008).  Among Korean American 
women, correlates of regular Pap testing included knowledge of guidelines, physician 
recommendation, having health insurance, and having family or friends who also receive 
Pap tests (Juon, Seung-Less, & Klassen, 2003).  Among Vietnamese Americans, being 
married, having a higher education level, having a female physician, having a respectful 
physician, requesting a Pap test, and physician recommendation were associated with 
receipt of a Pap test (Nguyen, McPhee, Nguyen, Lam, & Mock, 2002).  Among Thai 
women in Northern California, physician recommendation, insurance status, and primary 
language were predictors of Pap testing (Tsui & Tanjasiri, 2008).  Similarly, cervical 
cancer screening patterns have been studied among other subgroups.  According to the 
Health Information National Trends Survey, women with health insurance were more 
likely to adhere to cervical cancer screening than women without health insurance 
(Nelson et al., 2009).  Among non-Hispanic white and black women, insurance was 
associated with increased likelihood of receipt of a Pap smear (Hirth, Laz, Rahman, & 
Berenson, 2016).   
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Women living in rural areas may face barriers to receiving cervical cancer 
screening.  Among farm women from three states, non-adherence to Pap testing increased 
with age and decreased with education.  Up-to-date Pap testing was positively associated 
with obtaining a mammogram or breast examination in the past and being married 
(Carruth, Browning, Reed, Skarke, & Sealey, 2006).  Among Appalachian women, those 
who rarely or never had breast cancer screening were likely to be rarely or never screened 
for cervical cancer as well (Schoenberg et al., 2013).  In two rural Oregon communities, 
women over 55 years of age with co-morbidities such as arthritis, diabetes mellitus, and 
hypertension were less likely to be up-to-date for cervical cancer screening as compared 
to women without chronic conditions (Liu et al., 2014).  
Region of residence within the United States has also been shown to be a 
predictor of cervical cancer screening.  Women residing in the West region of the United 
States were less likely to have had cervical cancer screening, while women residing in the 
Southern region of the United States were more likely (Miles-Richardson et al., 2017).  
Most surveys ask women to select their marital status (Clark et al., 2009).  Marital 
status has been determined to be associated with cancer screening participation, such as 
for colorectal cancer screening (El-Haddad, Dong, Kallail, Hines, & Ablah, 2015).  In 
addition, marital status impacts cancer outcomes (Aizer et al., 2013).  Previous studies 
have shown that unmarried women were more likely to be diagnosed with a late stage of 
cervical cancer (Saghari, Ghamsary, Marie-Mitchell, Oda, & Morgan, 2015).   
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Acculturation 
Among recent immigrants, 73% reported having a Pap smear in the previous two 
years as compared to 89% of U.S. born women.  Uninsured U.S. born women were more 
likely to have a Pap smear than uninsured recent immigrant women (Carrasquillo & Pati, 
2004).  Among Chinese American immigrants, having insurance or a regular healthcare 
provider had better odds of Pap test use and adherence (Lee-Lin et al., 2007). 
African American women have been shown to be three times more likely to self-
report undergoing a current Pap smear than African-born women (Forney-Gorman & 
Kozhimannil, 2016).  Older Chinese American women with more traditional cultural 
views were less likely to be screened regularly, and those with higher English proficiency 
were more likely to have received regular Pap tests as compared to women with lower 
proficiency (Ji et al., 2010).  Cultural beliefs about the etiology of cervical cancer affect 
Pap testing among immigrant women (McMullin, De Alba, Chavez, & Hubbell, 2005). 
 
Access to Care and Utilization 
 Private health insurance and a usual source of care have been shown to have a 
bigger impact on cervical cancer screening adherence as compared to being uninsured 
and having no usual source of care (White et al., 2017 and Watson et al., 2017).  At least 
one doctor’s visit in the last year has been demonstrated to be associated with screening 
adherence (Ashok, Berkowitz, Hawkins, Tangka, & Saraiya, 2012; Nelson et al., 2009). 
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Chronic Conditions 
There has been conflicting findings on the association between chronic diseases 
and breast, cervical, and colorectal cancer screenings.  Some studies have found that 
chronic conditions such as diabetes are a barrier to cancer screening, while other studies 
have found that chronic diseases increase the likelihood of cancer screening adherence 
(Brown, Hossain, & Forrester, 2013; Liu et al., 2014; Lukin et al., 2012).  Pap testing 
compliance among women with and without cardiovascular disease was similar.  
Myocardial infarction was associated with reduced odds of Pap test compliance (Guo, 
Hirth, & Berenson, 2015).   A study conducted in Oregon found that women with 
arthritis, diabetes mellitus, and hypertension were less likely to adhere to cervical cancer 
screening compared with women without chronic conditions (Liu et al., 2014).  Among 
American Indian and Alaska Native women, presence of one or more chronic medical 
conditions was one of the predictors of Pap test use (Schumacher et al., 2008). 
 
Health Behaviors and Knowledge 
It has been found that lifestyle factors and behaviors, including obesity, dietary 
factors, alcohol intake, physical activity, oral contraceptives, and smoking affect risk of 
gynecological cancers (Rieck & Fiander, 2006).  Health status can include measures such 
as life expectancy, physical and mental health, self-assessment of health, physical activity 
and chronic illnesses (Office of Disease Prevention and Health Promotion [ODPHP], 
2018).  While studies have shown associations between health status and cancer 
screening, the findings vary.  According to the 2000 National Health Interview Survey, 
health behavior patterns including usual source of care were associated with cervical 
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cancer screening.  Usual source of care was the strongest correlate of Pap testing 
(Meissner et al., 2009).  Among women 18 to 29 years old, usual source of healthcare and 
current birth control use increased the chances of having a Pap test within the last 12 
months (Roland et al., 2013).  No primary care provider and lack of usual source of care 
were associated with lower rates of Pap testing (Hewitt et al., 2004).  Adherence to Pap 
testing is also associated with normal body mass index, being a non-smoker, and no 
mood disturbance (Nelson et al., 2009).   
Some studies have shown an association between higher levels of physical 
activity and higher rates of cancer screening.  In addition, increased physical activity is 
associated with higher odds of Pap testing among American Indian women (Muus et al., 
2012).  Women with a normal BMI were more likely to adhere to regular Pap testing 
compared with obese women (Nelson et al., 2009).  Women with BMIs greater than 40 in 
the United States were less likely to have a Pap test within three years, and women with 
BMIs >30 were less likely to adhere to physician recommendation for a Pap test 
(Ferrante, Chen, Crabtree, & Wartenberg, 2007).  Non-Hispanic black women with BMIs 
between 25 and 30 were less likely to receive a Pap smear than black women with BMIs 
< 25 (Hirth et al., 2016).  A systematic review showed an inverse association between 
obesity and cervical cancer among non-Hispanic white women (Maruthur, Bolen, 
Brancati, & Clark, 2009).  Underweight women, overweight women, and obese women 
are more likely to delay Pap testing by more than two years compared with women with 
normal weight (Fontaine, Heo, & Allison, 2001).  A higher proportion of obese non-
Hispanic white women compared with women of normal weight reported not undergoing 
Pap testing due to putting it off, being embarrassed, or discomfort.  Among women who 
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did not undergo screening, obese women were just as likely as women with normal 
weight to receive a physician recommendation for Pap testing (Wee, Phillips, & 
McCarthy, 2005).  Studies have shown that lack of physician recommendation to receive 
a Pap smear may lead to underutilization of Pap smears (Coughlin, Breslau, Thompson, 
& Benard, 2005). 
History of family cancer has had a positive association with cancer screening in 
some studies (Bostean, Crespi, & McCarthy, 2013; Carney et al., 2013; Qin, White, 
Sabatino, & Febo-Vazquez, 2018; Shah et al., 2007).  Non-Hispanic white and black 
women with a family history of cancer were 42% more likely to have had a recent Pap 
test than those without a family history of cancer, and non-Hispanic black women with a 
family history of cancer were more likely to have had a recent Pap test than non-Hispanic 
white women with or without a family history of cancer (Williams, Reiter, Mabiso, 
Maurer, & Paskett, 2009).  In contrast, a population-based study on women in 
Southeastern United States showed no association between family history of cancer and 
cervical cancer screening (Bellinger et al., 2013). 
Systematic reviews have shown a positive association between education and 
cervical cancer screening (Damiani et al., 2015), as well as between health literacy and 
cervical cancer (Kim & Han, 2016).  Educational attainment has been shown to have a 
significant correlation with knowledge of cervical cancer risk factors (Akinlotan et al., 
2017).  Many studies regarding education, knowledge, and perceptions focus on specific 
ethnic groups.  Korean American women with low education levels and low English 
proficiency have lower rates of Pap testing than those with high education levels and 
English proficiency.  The most common reason for lack of regular Pap testing among the 
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Korean American women studied was the belief that it was not necessary if no symptoms 
were present (Juon et al., 2003).  Cancer education has been shown to be an important  
predictor of cervical cancer screening among uninsured, urban Hispanic women (Buki, 
Jamison, Anderson, & Cuadra, 2007).   
One study found that absolute and comparative risk perceptions were not 
significant predictors of cervical cancer screening adherence, but risk perception had an 
indirect effect on screening through cancer worry.  As women’s risk perception 
increased, their worry of developing cancer also increased, which was associated with 
increased screening adherence (Zhao & Nan, 2016).  Recent cervical cancer screening 
has been shown to be associated with knowledge of cancer risk factors and perceptions of 
cancer survival (Pearlman, Clark, Rakowski, & Ehrich, 1999). 
Adherence to Pap testing is associated with normal body mass index, being a non-
smoker, no mood disturbance, and being knowledgeable about Pap testing and human 
papillomavirus infection (Nelson et al., 2009).     
 Predictors for never having been screened for cervical cancer are residence in a 
central city or the Northeast.  Some of these predictors change when analyzing those who 
had not been screened recently (Calle et al., 1993).  Among African Americans and 
Hispanics in three urban public housing communities in Los Angeles, 62% had received 
cervical cancer screening within the past year, and 29% stated that no health care 
provider recommended cervical cancer screening to them.  Affordability, continuity of 
care, and physician recommendation predicted adherence to cervical cancer screening 
(M. Bazargan, S. Bazargan, Farroq, & Baker, 2004). 
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The PRECEDE-PROCEED Model 
 The PRECEDE/PROCEED model integrates social, epidemiologic, behavioral, 
environmental, education, and organizational perspectives of health concerns.  
PRECEDE stands for predisposing, reinforcing, and enabling constructs in 
educational/environmental diagnosis and evaluation.  PROCEED stands for policy, 
regulatory, and organization constructs in educational and environmental development.  
The predisposing, reinforcing, and enabling factors are contributing factors that influence 
behavioral and environmental change.  Predisposing factors include knowledge, attitudes, 
beliefs, and some sociodemographic characteristics.  Enabling factors include cost, 
transportation, and environmental issues.  Reinforcing factors include social support, 
physician/patient relationship, and peer influence (Hatcher et al., 2011; Ji et al., 2010).   
In this study, predisposing, enabling, and reinforcing factors were assessed as 
predictors of cervical cancer screening.  Predisposing factors included age, race/ethnicity, 
education, chronic conditions, HPV knowledge, age when first child born, perceived risk 
of breast cancer, and perceived health status (Bautista, Vila, Uso, Tellez, & Zanon, 2006; 
Chen, Yamada, & Smith, 2014; Palli, Mehta, & Aparasu, 2012; Studts, Tarasenko, & 
Schoenberg, 2013).  Enabling factors included employment status, acculturation, and 
access to care and utilization (Chen et al., 2014; Palli et al., 2012; Palmer, Midgette, & 
Dankwa, 2008; Studts et al., 2013).  Reinforcing factors included marital status and 
physician recommendation (Studts et al., 2013). 
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Figure 1:  The PRECEDE/PROCEED Model 
 
Source:  McKenzie et al., 2008 
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Gaps in knowledge about cervical cancer screening among women in the U.S. 
First, few studies are available that used recent and robust national data on 
cervical cancer screening (Miles-Richardson et al., 2017; Watson et al., 2017; White et 
al., 2017).  Many studies explore specific races/ethnicities, geographic regions, age 
groups, and other demographic characteristics, but they are not generalizable to all U.S. 
women who fit the criteria for cervical cancer screening (Fedewa, Sauer, DeSantis, 
Siegel, & Jemal, 2017; Guo et al., 2015; Kepka et al., 2014; Roland et al., 2013).  
Second, few national studies among United States women used the most current 
screening guidelines of Pap test only or Pap/HPV co-testing in defining adherence 
(Watson et al., 2017; White et al., 2017).   Finally, limited information is available on 
cervical cancer screening among unmarried women, physician recommendations for 
cervical cancer screening, and adherence to physician recommendations (Clark et al., 
2009; Coughlin et al., 2005; De Alba & Sweningson, 2006; Hanske et al., 2016; Politi, 
Clark, Rogers, McGarry, & Sciamanna, 2008).      
 
REFERENCES 
Aizer, A.A., Chen, M.H., McCarthy, E.P., Mendu, M.L., Koo, S., Wilhite, 
T.J.,…Hoffman, K.E. (2013).  Marital status and survival in patients with cancer.  
Journal of  Clinical Oncology, 31(31), 3869-3876. 
 
Akinlotan, M., Bolin, J.N., Helduser, J., Ojinnaka, C., Lichorad, A., & McClellan, D. 
(2017).  Cervical cancer screening barriers and risk factor knowledge among uninsured 
women.  Journal of Community Health, 42(4), 770-778. 
 
Ashok, M., Berkowitz, Z., Hawkins, N.A., Tangka, F., & Saraiya, M. (2012).  Recency of 
Pap testing and future testing plans among women aged 18-64:  Analysis of the 2007 
Health Information National Trends Survey.  Journal of Women’s Health, 21(7), 705-
712. 
 
27 
 
Bautista, D., Vila, B., Uso, R., Tellez, M., & Zanon, V. (2006).  Predisposing, 
reinforcing, and enabling factors influencing influenza vaccination acceptance among 
healthcare workers.  Infection Control and Hospital Epidemiology, 27(1), 73-77. 
 
Bazargan, M., Bazargan, S.H., Farooq, M., & Baker, R.S. (2004).  Correlates of cervical 
cancer screening among underserved Hispanic and African American women.  
Preventive Medicine, 39(3), 465-473. 
 
Bellinger, J.D., Brandt, H.M., Hardin, J.W., Bynum, S.A., Sharpe, P.A., & Jackson, D. 
(2013).  The role of family history of cancer on cervical cancer screening behavior in a 
population-based survey of women in the Southeastern United States.  Womens Health 
Issues, 23(4), 197-204. 
 
Bostean, G., Crespi, C.M., & McCarthy, W.J. (2013).  Associations among family history 
of cancer, cancer screening and lifestyle behaviors:  a population-based study.  Cancer 
Causes Control, 24(8), 1491-1503. 
 
Brown, S.R., Hossain, M.B., & Forrester, I.T. (2013).  Associations between cholesterol, 
colon cancer screening, behavior, and diet.  American Journal of Health Behavior, 37(3), 
360-368. 
 
Buki, L.P., Jamison, J., Anderson, C.J., & Cuadra, A.M. (2007).  Differences in 
predictors of cervical and breast cancer screening by screening need in uninsured Latina 
women.  Cancer, 110(7), 1578-1585. 
 
Calle, E.E., Flanders, W.D., Thun, M.J., & Martin, L.M. (1993).  Demographic predictors 
of mammography and pap smear screening in U.S. women.  American Journal of Public 
Health 83(1), 53-60. 
 
Carney, P.A., O’Malley, J.P., Gough, A., Buckley, D.I., Wallace, J., Fagnan, 
L.,…Lieberman, D. (2013).  Association between documented family history of cancer 
and screening for breast and colorectal cancer.  Preventive Medicine, 57(5), 679-684. 
 
Carrasquillo, O., & Pati, S. (2004).  The role of health insurance on pap smear and 
mammography utilization by immigrants living in the United States.  Preventive 
Medicine, 39(5), 943-950. 
 
Carruth, A.K., Browning, S., Reed, D.B., Skarke, L., & Sealey, L. (2006).  The impact of 
farm lifestyle and health characteristics:  Cervical cancer screening among southern 
farmwomen.  Nursing Research 55(2), 121-127. 
 
Chen, C., Yamada, T., & Smith, J. (2014).  An evaluation of healthcare information on 
the Internet:  The case of colorectal cancer prevention.  International Journal of 
Environmental Research and Public Health, 11(1), 1058-1075. 
 
28 
 
Chen, H., Kessler, C.L., Mori, N., & Chauhan, S.P. (2012).  Cervical cancer screening in 
the United States, 1993-2010:  Characteristics of women who are never screened.  
Journal of Women’s Health, 21(11), 1132-1138. 
 
Clark, M.A., Rogers, M.L., Armstrong, G.F., Rakowski, W., Bowen, D.J., Hughes, T., & 
McGarry, K.A. (2009).  Comprehensive cancer screening among unmarried women aged 
40-75 years:  Results from the cancer screening project for women.  Journal of Women’s 
Health, 18(4), 451-459. 
 
Coughlin, S.S., Breslau, E.S., Thompson, T., & Benard, V.B. (2005).  Physician 
recommendation for papanicoloau testing among U.S. women, 2000.  Cancer 
Epidemiology, Biomarkers and Prevention, 14(5), 1443-1148. 
 
Damiani, G., Basso, D., Acampora, A., Bianchi, C.B., Silvestrini, G., Frisicale, 
E.M.,…Ricciardi, W. (2015).  The impact of level of education on adherence to breast 
and cervical cancer screening:  Evidence from a systematic review and meta-analysis.  
Preventive Medicine, 81, 281-289. 
 
De Alba, I., & Sweningson, J.M. 2006.  English proficiency and physicians’ 
recommendation of Pap smears among Hispanics.  Cancer Detection and Prevention, 
30(3), 292-296. 
 
El-Haddad, B., Dong, F., Kallail, K.J., Hines, R.B., & Ablah, E. (2015).  Association of 
marital status and colorectal cancer screening participation in the USA.  Colorectal 
Disease, 17(5), O108-O114. 
 
Fedewa, S.A., Sauer, A.G., DeSantis, C., Siegel, R.L., & Jemal, A. (2017).  Disparities in 
cancer screening by occupational characteristics.  Preventive Medicine, 105, 311-318. 
 
Ferrante, J.M., Chen, P., Crabtree, B.F., & Wartenberg, D. (2007).  Cancer screening in 
women:  BMI and adherence to physician recommendations.  American Journal of 
Preventive Medicine, 32(6), 525-531. 
 
Fontaine, K.R., Heo, M., & Allison, D.B. (2001).  Body weight and cancer screening 
among women.  Journal of Women’s Health and Gender-Based Medicine, 10(5), 463-
470. 
 
Forney-Gorman, A., & Kozhimannil, K.B. (2016).  Differences in cervical cancer 
screening between African-American versus African-born black women in the United 
States.  Journal of Immigrant and Minority Health, 18(6), 1371-1377. 
 
Guo, F., Hirth, J.M., & Berenson, A.B. (2015).  Cervical cancer screening among women 
≥70 years of age in the United States – A referral problem or patient choice.  Preventive 
Medicine, 81, 427-432. 
 
29 
 
Hanske, J., Meyer, C.P., Sammon, J.D., Choueiri, T.K., Menon, M., Lipsitz, 
S.R.,…Trinh, Q. (2016).  The influence of marital status on the use of breast, cervical, 
and colorectal cancer screening.  Preventive Medicine, 89, 140-145. 
 
Hatcher, J., Studts, C.R., Dignan, M.B., Turner, L.M., & Schoenberg, N.E. (2011).  
Predictors of cervical cancer screening for rarely or never screened rural Appalachian 
women.  Journal of Health care for the Poor and Underserved, 22(1), 176-193. 
 
Hewitt, M., Devesa, S.S., & Breen, N. (2004).  Cervical cancer screening among U.S. 
women:  Analyses of the 2000 National Health Interview Survey.  Preventive medicine, 
39(2), 270-278. 
 
Hirth, J.M., Laz, T.H., Rahman, M., & Berenson, A.B. (2016).  Racial/ethnic differences 
affecting adherence to cancer screening guidelines among women.  Journal of Women’s 
Health 25(4), 371-380. 
 
Ji, C.S., Chen, M., Sun, J., & Liang, W. (2010).  Cultural views, English proficiency and 
regular cervical cancer screening among older Chinese American women.  Women’s 
Health Issues, 20(4), 272-278. 
 
Juon, H., Seung-Lee, C., & Klassen, A.C. (2003).  Predictors of regular Pap smear among 
Korean-American women.  Preventive Medicine, 37(6), 585-592. 
 
Kepka, D., Breen, N., King, J.B., Meissner, H.I., Roland, K.B., Benard, V.B., & Saraiya, 
M. (2014).  Demographic factors associated with overuse of Pap testing.  American 
Journal of Preventive Medicine, 47(5), 629-633. 
 
Kim, K., & Han, H. (2016).  Potential links between health literacy and cervical cancer 
screening behaviors:  a systematic review.  Psycho-Oncology, 25(2), 122-130. 
 
Lee-Lin, F., Pett, M., Menon, U., Lee, S., Nail, L., Mooney, K., & Itano, J. (2007).  
Cervical cancer beliefs and Pap test screening practices among Chinese American 
immigrants.  Oncology Nursing Forum 34(6), 1203-1209. 
 
Liu, B.Y., O’Malley, J., Mori, M., Fagnan, L.J., Lieberman, D., Morris, C.D.,…Carney, 
P.A. (2014).  The association of type and number of chronic diseases with breast, 
cervical, and colorectal cancer screening.  Journal of the American Board of Family 
Medicine, 27(5), 669-681. 
 
Lukin, D.J., Jandorf, L.H., Dhulkifl, R.J., Thelemaque, L.D., Christie, J.A., Itzkowitz, 
S.H., & DuHamel, K.N. (2012).  Effect of cormorbid conditions on adherence to 
colorectal cancer screening.  Journal of Cancer Education, 27(2), 269-276. 
 
 
 
30 
 
Maruthur, N.M., Bolen, S.D., Brancati, F.L., & Clark, J.M. (2009).  The association of 
obesity and cervical cancer screening:  a systematic review and meta-analysis.  Obesity, 
17(2), 375-381. 
 
McMullin, J.M., De Alba, I., Chavez, L.R., & Hubbell, F.A. (2005).  Influence of beliefs 
about cervical cancer etiology on Pap smear use among Latina immigrants.  Ethnicity and 
Health, 10(1), 3-18. 
 
Meissner, H.I., Yabroff, K.R., Dodd, K.W., Ballard-Barbash, R., & Berrigan, D. (2009).  
Are patterns of health behavior associated with cancer screening?  American Journal of 
Health Promotion, 23(3), 168-175. 
 
Miles-Richardson, S., Allen, S., Claridy, M.D., Booker, E.A., & Gerbi, G. (2017).  
Factors associated with self-reported cervical cancer screening among women aged 18 
years and older in the United States.  Journal of Community Health, 42(1), 72-77. 
 
Muus, K.J., Baker-Demaray, T.B., Bogart, T.A., Duncan, G.E., Jacobsen, C., Buchwald, 
D.S., & Henderson, J.A. (2012).  Physical activity and cervical cancer testing among 
American Indian women.  The Journal of Rural Health, 28(3), 320-326. 
 
Nelson, W., Moser, R.P., Gaffey, A., & Waldron, W. (2009).  Adherence to cervical 
cancer screening guidelines for U.S. women aged 25-64:  Data from the 2005 health 
information national trends survey (HINTS).  Journal of Women’s Health 18(11), 1759-
1768. 
 
Nguyen, T.T., McPhee, S.J., Nguyen, T., Lam, T., & Mock, J. (2002).  Predictors of 
cervical Pap smear screening  awareness, intention, and receipt among Vietnamese-
American women.  American Journal of Preventive Medicine 23(3), 207-214. 
 
Office of Disease Prevention and Health Promotion (2018).  General health status.  
Retrieved from https://www.healthypeople.gov/2020/about/foundation-health-
measures/General-Health-Status. 
 
Palli, S.R., Mehta, S., & Aparasu, R.R. (2012).  Prevalence and predictors of human 
papillomavirus vaccination in adolescent girls.  Journal of the American Pharmacists 
Association, 52(1), 52-58. 
 
Palmer, R.C., Midgette, L.A., & Dankwa, I. (2008).  Colorectal cancer screening and 
African Americans:  Findings from a qualitative study.  Cancer Control, 15(1), 72-79. 
 
Pearlman, D.N., Clark, M.A., Rakowski, W., & Ehrich, B. (1999).  The importance of 
knowledge and perceived cancer survivability.  Women and Health, 28(4), 93-112. 
 
 
 
31 
 
Politi, M.C., Clark, M.A., Rogers, M.L., McGarry, K., & Sciamanna, C.N. (2008).  
Patient-provider communication and cancer screening among unmarried women.  Patient 
Education and Counseling, 73(2), 251-255. 
 
Qin, J., White, M.C., Sabatino, S.A., & Febo-Vazquez, I. (2018).  Mammography use 
among women aged 18-39 years in the United States.  Breast Cancer Research and 
Treatment, 168(3), 687-693. 
 
Rieck, G., & Fiander, A. (2006).  The effect of lifestyle factors on gynaecological cancer.  
Best Practice & Research Clinical Obstetetrics & Gynaecology, 20(2), 227-251. 
 
Roland, K.B., Benard, V.B., Soman, A., Breen, N., Kepka, D., & Saraiya, M. (2013).  
Cervical cancer screening among young adult women in the United States.  Cancer, 
Epidemiology, Biomarkers and Prevention 22(4), 580-588. 
 
Saghari, S., Ghamsary, M., Marie-Mitchell, A., Oda, K., & Morgan, J.W. (2015).  
Sociodemographic predictors of delayed-versus early-stage cervical cancer in California.  
Annals of Epidemiology, 25(4), 250-255. 
 
Schoenberg, N.E., Studts, C.R., Hatcher-Keller, J., Buelt, E., & Adams, E. (2013).  
Patterns and determinants of breast and cervical cancer non-screening among 
Appalachian women.  Women and Health, 53(6), 552-571. 
 
Schumacher, M.C., Slattery, M.L., Lanier, A.P., Ma, K., Edwards, S., Ferucci, E.D., & 
Tom-Orme, L. (2008).  Prevalence and predictors of cancer screening among American 
Indian and Alaska native people:  the EARTH study.  Cancer Causes Control, 19(7), 
725-737. 
 
Shah, M., Zhu, K., Palmer, R.C., Jatoi, I., Shriver, C., & Wu, H. (2007).  Breast, 
colorectal, and skin cancer screening practices and family history of cancer in U.S. 
women.  Journal of Women’s Health, 16(4), 526-534. 
 
Studts, C., Tarasenko, Y.N., & Schoenberg, N.E. (2013).  Barriers to cervical cancer 
screening among middle-aged and older rural Appalachian women.  Journal of 
Community Health, 38(3), 500-512. 
 
Tsui, J., & Tanjasiri, S.P. (2008).  Cervical cancer screening among Thai women in 
Northern California.  Journal of Women’s Health, 17(3), 393-401.   
 
Watson, M.,  Benard, V., King, J., Crawford, A., & Saraiya, M. (2017).  National 
assessment of HPV and Pap tests:  Changes in cervical cancer screening, National Health 
Interview Survey.  Preventive Medicine, 100, 243-247. 
 
 
 
32 
 
Wee, C.C., Phillips, R.S., & McCarthy, E.P. (2005).  BMI and cervical cancer screening 
among white, African-American, and Hispanic women in the United States.  Obesity, 
13(7), 1275-1280. 
 
White, A., Thompson, T.D., White, M.C., Sabatino, S.A., de Moor, J., Doria-Rose, 
P.V.,… Richardson, L.C. (2017).  Cancer screening test use – United States, 2015.  
Morbidity and Mortality Weekly Report, 66 (8), 201-206. 
 
Williams, K.P., Reiter, P., Mabiso, A., Maurer, J., & Paskett, E. (2009).  Family history 
of cancer predicts Papanicolaou screening behavior for African American and White 
women.  Cancer, 115(1), 179-189. 
 
Zhao, X., & Nan, X. (2016).  The influence of absolute and comparative risk perceptions 
on cervical cancer screening and the mediating role of cancer worry.  Journal of Health 
Communication, 21(1), 100-108. 
  
33 
 
CHAPTER III. 
METHODOLOGY 
Overview 
This study used cross-sectional secondary data from the 2015 National Health 
Interview Survey, a nationally representative survey sample of the civilian 
noninstitutionalized United States population, to explore predictors of cervical cancer 
screening among women aged 21 to 65 years and among unmarried women compared to 
married women.  This study also assessed predictors of physician recommendation for 
cervical cancer screening and adherence to physician recommendation. 
 
Sample and description of data source 
The data source for this study was the 2015 National Health Interview Survey 
(NHIS) (National Center for Health Statistics, CDC, 2017).  The National Health 
Interview Survey is a cross-sectional household interview survey with a multistage area 
probability design that allows for representative sampling of household and non-
institutional group quarters.  The sampling plan is a sample of clusters of addresses in 
primary sampling units, which consist of a county, small group of contiguous counties, or 
a metropolitan statistical area (CDC, 2018). 
The NHIS questionnaire had a core set and supplemental sets of questions.  The 
core questionnaire consisted of household, family, sample adult, and sample child 
components.  The household component consisted of demographic information on all 
individuals in the household, and the family component collected additional demographic 
and health information on each family member in the household.  One adult and one child 
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were randomly selected from each family, and the sample adult core and the sample child 
core questionnaires were used to collect information respectively.  The supplemental 
questions included topics such as Healthy People objectives, cancer screening, 
complementary and alternative medicine, children’s mental health, and healthcare 
utilization (CDC, 2018).  The 2015 National Health Interview Survey contained data for 
41,493 households, containing 103,789 persons in 42,288 families.  The number of 
sample children is 12,291, and the number of sample adults is 33,672 (National Center 
for Health Statistics [NCHS], NHIS, 2015). 
 The sample for this study consisted of women who were between the ages of 21 
and 65.  Women who had a hysterectomy or a history of cervical cancer were excluded.  
The outcome variables were cervical cancer screening adherence, physician 
recommendation, and adherence to physician recommendation.  Cervical cancer 
screening adherence was defined as having had at least one Pap test during the last 3 
years, or for those 30-65 years of age by having had a Pap test and HPV test during the 
last 5 years.  Screening adherence was assessed by the following question: “When did 
you have your most recent pap test?”  “Did you have an HPV test with your most recent 
pap?” 
 Demographic, acculturation, access to care and utilization, chronic conditions, 
and health behaviors and knowledge variables were chosen based on existing literature 
and explored as predictors for Pap test adherence.  Demographic variables included age, 
race/ethnicity, marital status, education level, and employment status.  Marital status 
included the following categories:  married, widowed, separated, divorced, and never 
married.  Women who reported themselves as widowed, separated, or divorced were 
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considered to be previously married in this study.  Previously married and never married 
women were then combined to create a variable for unmarried women. 
Acculturation was assessed using the geographic region of birth, English 
proficiency, and period of U.S. residence variables.  Access to care variables included 
insurance type, office visits in past 12 months, and usual source of care.  A chronic 
condition variable combined who had hypertension, high cholesterol, congestive heart 
failure, heart disease, emphysema, chronic obstructive pulmonary disease, asthma, 
cancer, or diabetes.  Health behaviors and knowledge included BMI level, ever heard of 
HPV, ever received HPV vaccine, age when first child born, doctor recommended Pap 
test, birth control use, alcohol drinking status, smoking status, flu shot, risk perception of 
breast cancer, and reported health status.   
This study was reviewed by the Florida International University Office of 
Research Integrity, and it was determined to be non human subjects research due to the 
use of publically available de-identified data.  Therefore, it did not require further 
submission and approval of the FIU Institutional Review Board. 
 
Inclusion and exclusion criteria 
Sex:  This was a categorical variable defined as 1) male and 2) female.  Males 
were excluded from this study. 
Age:  This was a continuous variable and was recoded into categories of 21 to 29 
years, 30 to 39 years, 40 to 49 years, and 50 to 65 years based on previous literature 
(Watson et al., 2017).  Respondents less than 21 years and older than 65 years were 
excluded from this study based on current screening guidelines (USPSTF, 2016). 
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Hysterectomy:  Respondents who answered yes to the question “Have you had a 
hysterectomy?” were excluded from this study based on current screening guidelines 
(USPSTF, 2016). 
Cervical cancer:  Respondents who said they were told by a doctor or health 
professional that they had cervical cancer were excluded to ensure they underwent 
screening rather than surveillance (Hanske et al., 2016; Politi et al., 2008). 
Ever had a Pap smear/test:  Respondents who answered the question “Have you 
ever had a Pap smear or Pap test?” were included in this study. 
Among the 33,672 sample adults, 22,003 adults were excluded.  Exclusion criteria 
included being male (n=15,071), being younger than 21 years or older than 65 years old 
(n=5,119), having had a hysterectomy (n=1,734), and history of cervical cancer (n=79). 
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Figure 2:  Inclusion Criteria, Exclusion Criteria, and Study Aims 
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Outcome and predictor variables 
Cervical cancer screening adherence:  The questions for “when did you have your 
most recent Pap test” were combined to determine whether they had their last Pap test in 
the last 3 years, in the last 3 to 5 years, or more than 5 years ago.  Respondents who 
answered that they had their last Pap test in the last 3 years, or that they had their last Pap 
test in the last 3 to 5 years AND answered yes to “did you have an HPV test with your 
most recent Pap” were considered adherent to cervical cancer screening based on the 
2012 U.S. Preventive Services Task Force recommendations (USPSTF, 2016). 
Race/Ethnicity:  This was a categorical variable defined as 1) Hispanic, 2) non-
Hispanic white, 3) non-Hispanic black, 4) Asian, and 5) all other race groups (Watson et 
al., 2017). 
Marital status:  This was a categorical variable defined as 1) separated, 2) 
divorced, 3) married, 4) single/never married, and 5) widowed.  Separated and widowed 
were recoded into one category.  
Education level:  The highest level of school completed was recoded as less than 
high school, high school graduate or GED, some college or associate degree, and college 
graduate (Watson et al., 2017; White et al., 2017). 
Employment status:  Respondents were asked if they worked for pay at any time 
in the last calendar year with 1) yes and 2) no as the categories. 
Geographic region of birth:  This was a categorical variable to determine 
birthplace.  It was recoded into fewer categories:  United States, Mexico/Central 
America/Caribbean/South America, Europe/Russia, Africa, Middle East/Asia, and 
elsewhere. 
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English proficiency:  Respondents were asked how well they speak English, and 
the categories were recoded into very well/well and not well/not at all. 
Period of U.S. residence:  This was a categorical variable, which was recoded as 
having been born in the United States, living in the United States for 10 years or more , 
and living in the United States for fewer than 10 years (Watson et al., 2017; White et al., 
2017). 
Health care coverage:  This was a categorical variable defined as 1) private, 2) 
Medicaid and other public, 3) other coverage, and 4) uninsured (Watson et al., 2017). 
Outpatient clinic visits in past 12 months:  Total number of office visits in the past 
12 months were recoded as none, one, two to three, and four or more. 
Usual source of care:  The questions “Is there a place that you usually go to when 
you are sick or need advice about your health” and “what kind of place is it” were 
combined to create two categories:  Has usual source of care and none/hospital 
emergency department (Watson et al., 2017; White et al., 2017). 
Chronic conditions:  This variable combined respondents who had ever been told 
that they have hypertension, high cholesterol, congestive heart failure, heart disease, 
emphysema, chronic obstructive pulmonary disease, asthma, cancer, or diabetes.   
Body mass index (BMI):  This was a continuous variable, which was recoded into 
categories based on CDC guidelines:  less than 18.5 (underweight), 18.5-24.9 (normal), 
25-29.9 (overweight), 30 or greater (obese) (CDC, 2017b).  The equation for BMI is as 
follows:  BMI = [Weight (kg) / [Height (m) squared]]. 
Ever heard of HPV:  This was a categorical variable defined as 1) yes and 2) no. 
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Ever received HPV shot/vaccine:  This was a categorical variable defined as 1) 
yes and 2) no. 
Age when first child born:  The questions “have you ever given birth to a live 
born infant” and “how old were you when your child was born” were combined to create 
the following categories:  Never gave birth, less than 21 years, 21 to 29 years, and 30 
years or older. 
Physician recommendation:  Respondents were asked whether a doctor or other 
health professional recommended that they have a Pap test or Pap and HPV test in the 
past 12 months, with categories of 1) yes, 2) no, and 3) did not see a doctor in the last 12 
months. 
Birth control:  This was a categorical variable in which respondents answered yes 
or no to the question “Are you currently taking birth control pills, birth control implants, 
birth control shots, or have a birth control patch?” 
Alcohol drinking status:  This was a categorical variable, which was recoded as 
lifetime abstainer, former drinker, and current drinker.  A lifetime abstainers was defined 
as consuming fewer than 12 drinks in a lifetime. 
Smoking status:  This was a categorical variable, which was recoded as never 
smoker, former smoker, and current smoker. 
Flu shot in past 12 months:  This was a categorical variable defined as 1) yes and 
2) no. 
Risk perception of breast cancer:  Respondents were asked “Compared to the 
average women your age, would you say that you are more likely to get breast cancer,  
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less likely, or about as likely?”  The categories were recoded into more likely and less 
likely/about as likely. 
Reported health status:  This was a categorical variable defined as 1) excellent, 2) 
very good, 3) good, 4) fair, and 5) poor.  Excellent and very good were recoded into the 
same category, and fair and poor were recoded into the same category. 
 
Data management and preparation 
 The public use files were downloaded from the Centers for Disease Control, 
National Center for Health Statistics (NCHS) website 
(https://www.cdc.gov/nchs/nhis/nhis_2015_data_release.htm).  The 2015 Person, Sample 
Adult, and Cancer files were merged together to create one dataset.     
 
Statistical analysis 
Descriptive analyses were first performed to describe the sample by the selected 
variables for demographics, acculturation, access to care and utilization, chronic 
conditions, and health behaviors and knowledge.  The descriptive analyses included the 
total number in the sample, the percent of the sample that it represented, screening 
adherence percentages, and crude odds ratio with corresponding 95% confidence interval.   
Multiple logistic regression models were used to examine the relationship first 
between selected variables and the outcomes of interest (cervical cancer screening 
adherence and physician recommendation), and then analysis was performed by race to 
determine significant predictors.  Backward elimination and stepwise procedures were 
used for the selection of variables into the model.  Multicollinearity was tested for to 
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ensure predictors were not highly correlated.  SAS 7.12 was used to perform the analysis.  
All analyses included statistical weights to account for the complex survey design, 
oversampling, post-stratification, and survey nonresponse.  Weight, stratum, and cluster 
variables were used to specify the sample design.  SURVEY procedures and statements 
were used to allow for correct estimation from a complex sample. 
 
Missing 
 Missing data were coded as “.”.  Refused, not ascertained, and don’t know 
responses to survey questions were treated as missing data.  Missing data were not 
included in this study.  The percentage of missing data for each variable was assessed. 
Among the 11,669 eligible women, 1,002 (8.6%) women were coded as “refused” 
(n=42), “not ascertained” (n=934), or “don’t know” (n=26) for the question “Have you 
ever had a Pap smear or Pap test”.  “Not ascertained” was used for partially completed 
interviews where the participant discontinued the interview.  The non-respondents were 
not included in this study, as supported by other studies using the National Health 
Interview Survey (Blackwell & Clarke, 2016; Blackwell & Clarke, 2018; Clarke, Nahin, 
Barnes, & Stussman, 2016; Nahin, Barnes, & Stussman, 2016; Ward, Dahlhamer, 
Galinsky, & Joestl, 2014).  The respondents compared to non-respondents were similar 
when analyzed by age, race/ethnicity, marital status, education level, and employment 
status, and determined to be randomly missing.  The final sample size was 10,667 
women. 
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Weighting 
 Each person in the NHIS sample has a known non-zero probability of selection, 
which is reflected in sample weights in order to provide unbiased national estimates.  The 
base weights are adjusted for non-response and post-stratification to create final sampling 
weights.  
Beginning with the 2010 National Health Interview Survey, the National Center 
for Health Statistics added a nonresponse adjustment for the sample adult weight.  The 
sample adult weight includes design, ratio, non-response, and poststratification 
adjustments for sample adults.  National estimates of all sample adult variables can be 
made using these weights (NCHS, NHIS, 2015). 
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CHAPTER IV. 
MANUSCRIPT 1 
Predictors of cervical cancer screening among a nationally representative sample of 
women in the United States using current screening guidelines: 2015 National 
Health Interview Survey 
 
Abstract 
Background:  Cervical cancer is one of the most preventable diseases if diagnosed early, 
but adherence to cervical cancer screening guidelines remains suboptimal.  The objective 
of this study was to identify demographic, acculturation, access to health care and health 
behavior and knowledge factors associated with adherence to the current cervical cancer 
screening guidelines, and to determine if these factors differed by race/ethnicity.  
Methods:  The 2015 National Health Interview Survey data were used to analyze cervical 
cancer screening adherence behavior in a sample of 10,667 women.  Demographic, 
acculturation, access to care and utilization, chronic condition, and health behavior and 
knowledge variables were analyzed using logistic regression for the entire group and then 
stratified by race.  The outcome of cervical cancer screening adherence was developed 
based on current guidelines of having a Pap test in the last three years, or co-testing with 
a Pap test and HPV test in the last five years.  Results:  Among these women, 81.7% 
(95% CI 80.7-82.7%) adhered to cervical cancer screening.  Screening adherence 
declined with increasing age after the age of 39 years.  Women who were never married 
(adjusted odds ratio [aOR] 0.67, CI 0.56-0.79) or current smokers (aOR 0.70, CI 0.59-
0.84) had lower odds to adhere to cervical cancer screening guidelines.  Women with a 
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college degree had greater odds to adhere to cervical cancer screening guidelines (aOR 
1.38, CI 1.14-1.67).  Positive health behaviors indicative of visiting a doctor were 
significantly associated with adhering to cervical cancer screening guidelines.  
Conclusion:  Enhanced education about the importance of cervical cancer screening and 
targeted interventions are needed for women aged under 30 and over 40 years, unmarried, 
unemployed, uninsured women, women with less education, women with no usual source 
of care, and current smokers.   
 
Background 
Previously one of the most common cancers among women in the United States, 
cervical cancer now ranks as the 21
st
 most common types of cancer (NCI, n.d.).  In the 
United States from 2009 to 2013, the incidence rate of cervical cancer was 7.5 per 
100,000 women per year, and the mortality rate was 2.3 deaths per 100,000 women.  The 
risk that a woman will develop cervical cancer during her lifetime is 0.6 percent (NCI, 
n.d.).   Hispanic women had the highest incidence of cervical cancer, followed by non-
Hispanic black, white, American Indian/Alaska Native, and Asian/Pacific Islander 
women.  Non-Hispanic black women had the highest mortality rate, followed by 
Hispanic, Asian/Pacific Islander, non-Hispanic white, and American Indian/Alaska 
Native women (CDC, 2015). 
Cervical cancer is highly preventable when screening and follow-up 
recommendations are adhered to (CDC, 2015).  If cervical cancer is diagnosed at an early 
stage, it is treatable and associated with long survival (CDC, 2015).  The five-year 
observed survival rate decreases as the disease progresses.  The five-year survival rate is 
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93% at stage 0, 93% at stage IA, 80% at stage IB, 63% at stage IIA, 58% at IIB, 35% at 
stage IIIA, 32% at stage IIIB, 16% at IVA, and 15% at stage IVB (ACS, 2016).  Cervical 
cancer is a slow-growing cancer, making it one of the most preventable cancers (NCCC, 
2016).   
Secondary prevention through cervical cancer screening identifies cervical 
abnormalities.  Cervical cancer deaths have decreased by 50% over the last 40 years due 
to an increase in Pap test utilization (ACS, 2018).  However, from 2008 to 2010, cervical 
cancer screening rates declined slightly (Brown et al., 2014).  According to the U.S. 
Preventive Task Force, a Pap test is recommended for women between the ages of 21 and 
65 years of age who have not had a hysterectomy.  Recommendations for frequency of 
cervical cancer screening have changed over the years.  Currently, a Pap test is 
recommended every three years.  Cervical cancer screening is only recommended every 
five years if there is co-testing with the HPV test.  These recommendations do not apply 
to women with a diagnosis of a high-grade precancerous cervical lesion or cervical 
cancer, women with in utero exposure to diethylstilbestrol, women who are HIV infected, 
or women who are otherwise immunocompromised (USPSTF, 2016).  
 Many studies on cervical cancer screening focus on specific geographic regions or 
racial/ethnic groups.  While the findings of previous studies have been consistent on the 
association of demographic factors and cervical cancer screening, there are insufficient 
results on chronic diseases.  In addition, trends for some characteristics will vary over the 
years and may indicate different populations for further study.  Current analysis on 
robust, national data is warranted to identify or confirm predictors and to explore 
populations in need of interventions for the prevention of cervical cancer.  In 2012, HPV 
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and Pap co-testing for women over the age of 30 became a part of the cervical cancer 
screening guidelines.  There are two published articles which examined Pap test 
adherence by sociodemographic characteristics and health care access using NHIS 2015 
data.  One study examined Pap test within three years and co-testing within three years 
separately, while the other study combined both options together (White et al., 2017; 
Watson et al., 2017).  This study adds to current literature by taking current screening 
guidelines into account when determining the characteristics of who gets screened.  The 
characteristics examined will go beyond demographic and health care access to also 
assess the role of acculturation, chronic conditions, and health behavior and knowledge 
on screening.  The objective of this study was to identify demographic, acculturation, 
access to health care and health behavior and knowledge factors associated with 
adherence to the current cervical cancer screening guidelines and to determine if these 
factors differed by race/ethnicity.  Variables were chosen based on existing literature and 
considered as predisposing, reinforcing, or enabling factors using the 
PRECEDE/PROCEED model (Hatcher et al., 2011; Ji et al., 2010).  
 
Methods 
 The data source for this study was the 2015 National Health Interview Survey 
(NHIS) (National Center for Health Statistics, CDC, 2017).  The NHIS is a cross-
sectional household interview survey with a multistage area probability design that 
allowed for representative sampling of household and non-institutional group quarters.  
The sampling plan was a sample of clusters of addresses in primary sampling units, 
which consisted of a county, small group of contiguous counties, or a metropolitan 
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statistical area (CDC, 2018).  The 2015 Person, Sample Adult, and Cancer files were 
merged together.     
 The sample for this study consisted of women who were between the ages of 21 
and 65.  Women who had a hysterectomy or a history of cervical cancer were excluded.  
The outcome variable was cervical cancer screening adherence.  Cervical cancer 
screening adherence was defined by having had at least one Pap test during the last 3 
years, or for those 30-65 by having had a Pap test and HPV test during the last 5 years.  
Screening adherence was assessed by the following question: “When did you have your 
most recent pap test?”  “Did you have an HPV test with your most recent pap?” 
 Demographic, acculturation, access to care and utilization, chronic conditions, 
and health behaviors and knowledge variables were explored as predictors for Pap test 
adherence.  Demographic variables included age, race/ethnicity, marital status, education 
level, and employment status.  Acculturation was assessed using the geographic region of 
birth, English proficiency, and period of U.S. residence variables.  Access to care 
variables included insurance type, office visits in past 12 months, and usual source of 
care.  A chronic condition variable combined hypertension, high cholesterol, congestive 
heart failure, heart disease, emphysema, chronic obstructive pulmonary disease, asthma, 
cancer, or diabetes.  Health behaviors and knowledge included BMI level, ever heard of 
HPV, ever received HPV vaccine, age when first child born, doctor recommended pap 
test, birth control use, alcohol drinking status, smoking status, flu shot, risk perception of 
breast cancer, and reported health status.   
A multiple logistic regression model was used to examine the relationship first 
between selected variables and cervical cancer screening adherence, and then analysis 
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was performed by race to determine significant predictors.  Backward elimination and 
stepwise procedures were used for the selection of variables into the model.  
Multicollinearity was tested to ensure predictors were not highly correlated.  SAS 7.12 
was used to perform the analysis.  All analyses included statistical weights to account for 
the complex survey design, oversampling, post-stratification, and survey nonresponse.  
Weight, stratum, and cluster variables were used to specify the sample design.  SAS Proc 
SURVEY and its statements were used to allow for correct estimation from a complex 
sample.  This study was determined to be non human subjects research due to the use of 
publically available de-identified data.     
 
Results 
The sample consisted of 10,667 women between the ages of 21 and 65 without a 
hysterectomy or history of cancer, representing 75,830,736 women in the United States.  
Of these, 81.7% were adherent to cervical cancer screening.  Table 1 shows the 
distribution of characteristics among the sample and the crude odds of adherence for each 
characteristic.  Of all the age groups, women aged 21 to 29 years reported the lowest 
cervical cancer screening adherence (76.0%).  Cervical cancer screening adherence 
among non-Hispanic black and non-Hispanic white women was higher (84.2% and 
83.4%, respectively) than that among women belonging to Hispanic, Asian, and other 
racial/ethnic groups (77.8%, 72.6%, and 73.1%, respectively).  Cervical cancer screening 
adherence was higher among women who were married (85.5%) as compared to other 
marital statuses, and who were employed last year (84.5%).  Cervical cancer screening 
adherence increased with higher education.    
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Cervical cancer screening adherence was higher among women who spoke 
English well (82.5%) as compared to not well (69.6%).  Only 65.1% of women living in 
the United States for fewer than 10 years reported cervical cancer screening adherence as 
compared to 78.3% of women in the United States for 10 or more years, and 83.3% of 
women born in the United States.   
Cervical cancer screening adherence was higher among women who had private 
health insurance (85.6%).  Screening adherence increased as the number of outpatient 
clinic visits in the past 12 months increased, with four or more office visits in the prior 
year being the highest (88.1%).  Women who did not have a usual source of care had a 
lower percentage of screening adherence (64.9%) as compared to women who did have a 
usual source of care (84.4%).  Women who had at least one chronic condition (83.4%) 
had higher screening adherence as compared to women with no chronic conditions 
(80.3%).  Women with a BMI of 25-29.9 (overweight) had the highest percentage of 
screening adherence (82.5%) as compared to all other BMI categories.  Women with 
knowledge of HPV (85.9%) and receipt of the HPV vaccine (89.5%) had higher rates of 
cervical cancer screening adherence.  Screening adherence increased with increasing age 
of when the first child was born.  Women who did not have physician recommendation 
for a Pap test had lower screening adherence (78.5%) than those who did have physician 
recommendation (89.3%).  Among women using birth control pills, implants or shots, 
91.3% adhered to screening guidelines.  Current alcohol drinkers (85.5%) and former 
smokers (86.0%) had the highest rates of screening adherence as compared to those who 
abstained from alcohol (71.5%) or were never smokers (82.1%).  Women who had a flu 
shot in the past 12 months had a higher rate of screening adherence (88.5%).  Women 
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who perceived themselves to be less likely to get breast cancer as compared to average 
women had a lower percentage of adherence (81.5%).  Screening adherence was higher 
among women who reported excellent or good health status (82.4%) than among women 
who reported fair or poor health status (75.3%).   
We performed a multivariable analysis to calculate the odds ratios for cervical 
cancer screening adherence, adjusting for other variables (Table 1.2).  Non-Hispanic 
black women (aOR 2.26, 95% CI 1.83-2.80) and Hispanic women (aOR 1.47, 95% CI 
1.16-1.86) had higher odds of cervical cancer screening adherence as compared to non-
Hispanic white women.  Women between the ages of 30 and 39 had the highest 
likelihood of adhering to cervical cancer screening (aOR 1.59, 95% CI 1.30-1.94).  
Screening rates decreased after 39 years of age but were still higher than those among the 
21 to 29 year age group.  Compared with the youngest age group, those who were 30 to 
39 years of age had the highest odds to adhere to cervical cancer screening if non-
Hispanic white (aOR 1.71, 95% CI 1.16-2.53) or Hispanic (aOR 1.50, 95% CI 1.01-2.23) 
but not for non-Hispanic black women (aOR 1.33, 95% CI 0.70-2.50).  Women who were 
never married were least likely to adhere to cervical cancer screening as compared to 
other marital status (aOR 0.67, 95% CI 0.56-0.79).  Among non-Hispanic white and 
Hispanic women, never married compared to married women had lower odds of getting 
screened (aOR 0.48, 95% CI 0.35-0.68; and aOR 0.60, 95% CI 0.41-0.87, respectively), 
but there was no difference among non-Hispanic black women (aOR 0.95, 95%  CI 0.53-
1.72).  Higher odds of cervical cancer screening adherence were associated with being a 
college graduate (aOR 1.38, 95% CI 1.14-1.67) compared with other education levels, 
and with having worked last year compared with not having worked last year.  
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Graduation from college and having worked last year were significantly associated with 
screening among non-Hispanic white and black women but not for Hispanic women.  
Lower odds of screening adherence were associated with being born in the Middle East 
or Asia (aOR 0.62, 95% CI 0.38-0.99), being uninsured (aOR 0.72, 95% CI 0.59-0.88), 
having no office visits in the past 12 months (AOR 0.54, 95% CI 0.45-0.66), and having 
no usual source of care or using a hospital emergency department (aOR 0.68, 95% CI 
0.57-0.81).  Non-Hispanic white (aOR 0.66, 95% CI 0.45-0.97) and Hispanic (aOR 0.59, 
95% CI 0.37-0.94) women who were uninsured had lower odds to adhere to cervical 
cancer screening but were not significantly different than non-Hispanic black women 
(aOR 0.55, 95% CI 0.28-1.12).  Not having a usual source of care was a significant factor 
only among non-Hispanic white women (aOR 0.64, 95% CI 0.47, 0.87).  Women with no 
office visits in the past 12 months were less likely to adhere to cervical cancer screening 
among non-Hispanic white (aOR 0.52, 95% CI 0.34, 0.79), non-Hispanic black (aOR 
0.50, 95% CI 0.26-0.96), and Hispanic women (aOR 0.46, 95% CI 0.30-0.71).  
Higher odds of cervical cancer screening adherence were associated with having 
heard of HPV, having received an HPV shot, being over 30 years old when the first child 
was born, physician recommendation for a Pap test, birth control use, and having 
received a flu shot in the past 12 months.  Non-Hispanic white (aOR 0.56, 95% CI 0.35-
0.88) and Hispanic (aOR 0.43, 95% CI 0.25-0.76) women who had never received an 
HPV shot were less likely to adhere to cervical cancer screening but were not significant 
among non-Hispanic black women (aOR 0.88, 95% CI 0.46-1.70).  Women who 
currently drank alcohol compared with never drinkers had greater odds (aOR 1.50, 95% 
CI 1.27-1.76) to adhere to cervical cancer screening recommendations; whereas current 
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smokers had lower odds (aOR 0.70, 95% CI 0.59-0.84) than never smokers.  Women 
who had not heard of HPV, who had never given birth, with no physician 
recommendation for a Pap test, with no birth control use, and with no flu shot in the last 
12 months had lower odds to adhere to cervical cancer screening among non-Hispanic 
white, non-Hispanic black, and Hispanic women.  Alcohol drinking and smoking status 
and reported health status were only significant among non-Hispanic white women.  
Lower odds of screening adherence were associated with having reported fair or poor 
health status (aOR 0.72, 95% CI 0.59-0.88).  
 
Discussion 
  Recognizing cervical cancer as a highly preventable disease as well as needs for 
updated national data to determine which groups to target, we assessed 2015 NHIS data 
to identify predictors of cervical cancer screening as well as racial disparities.  In 
addition, we used the current guidelines of either having a Pap test in the last 3 years or 
having a Pap test and HPV test in the last 5 years as the outcome.  Among women aged 
21 to 65 years with no hysterectomy and no history of cervical cancer, 81.7% were 
adherent to cervical cancer screening guidelines.  This translates into 61,922,182 women.  
However, no group of women examined in this study reached the Healthy People 2020 
objective of 93% of women screened.  Women currently taking birth control pills, 
implants, or shots (91.3%) are the closest group to achieving this target.  We found a 
number of factors affected the screening behavior among women, which included 
race/ethnicity, age, marital status, education, work status, insurance, physician office 
visits, usual source of care, knowledge of HPV, HPV vaccination, age when first child 
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born, doctor recommendation, birth control use, alcohol and smoking status, flu shot in 
the last 12 months, and reported health status.   
Racial disparities are important to analyze to understand where additional 
resources are needed.  Stratified by race, differences in associated characteristics with 
adherence were evident. Overall, non-Hispanic black women were more than twice as 
likely as non-Hispanic white women to adhere to cervical cancer screening.  With non-
Hispanic black women having higher incidence and mortality rates for cervical cancer as 
compared to non-Hispanic white women, other factors, such as follow-up to abnormal 
pap test results, need to be studied to better understand this disparity.  Understanding the 
significant predictors by race is imperative in providing the appropriate education and 
interventions to targeted groups.   
In addition, recent studies have shown being non-Hispanic white reduced the 
likelihood of cervical cancer screening (Miles-Richardson et al., 2017).  There are racial 
and ethnic differences in the association of these demographic factors with cervical 
cancer screening.  Hispanic and other race women were more likely (11.1% and 14.7%, 
respectively) to never have a Pap test than non-Hispanic white women (5.0%) or black 
women (5.8%) (Chen et al., 2012).  Among non-Hispanic white and black women, 
insurance was associated with increased likelihood of receipt of a Pap smear (Hirth et al., 
2016).   
Our study found that women who were born in the Middle East or Asia were less 
likely to adhere to cervical cancer screening guidelines.  Studies have shown that foreign 
born women are less likely to adhere to Pap testing recommendations compared with 
women born in the United States.  There are further differences based on duration of time 
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spent in the United States and by birthplace (Tsui, Saraiya, Thompson, Dey, & 
Richardson, 2007).  Cultural beliefs about the etiology of cervical cancer affect Pap 
testing among immigrant women (McMullin et al., 2005). 
Our findings on the demographic variables and the percentage of adherence 
concurred with past research (White et al., 2017; Watson et al., 2017).  
Sociodemographic factors have been shown to be predictors of cervical cancer screening 
(Miles-Richardson et al., 2017).  According to the 2000 National Health Interview 
Survey, age, race/ethnicity, education, health insurance, and a usual source of care were 
associated with cervical cancer screening (Meissner et al., 2009).  With the median age of 
diagnosis of cervical cancer being 49 years, it is interesting to note our finding that the 
likelihood of screening declines after the age of 39.  This indicates a need for enhancing 
education to women over the age of 40 and to emphasize continued screening.  While it is 
crucial to start screening at the age of 21, it is important to adhere to current screening 
guidelines even as age increases to find any cervical cell changes at an early stage.  Non-
Hispanic white women and Hispanic women between the ages of 30 and 39 were most 
likely to get screened for cervical cancer as compared to other age groups, whereas age 
was not significant for non-Hispanic black women.  This may be a result of cultural 
beliefs and the age at which such services are deemed to be necessary.  In addition, they 
also may have been screened as part of obstetric care or when obtaining birth control.  
Women who did not work the previous year were 35% less likely to have adhered to 
cervical cancer screening guidelines. Women who did not work the previous year may 
have fewer financial resources for screening such as insurance and transportation, which 
may have hindered health seeking behaviors.  Women without insurance were 28% less 
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likely to adhere to cervical cancer screening guidelines, similar to women who did not 
work the previous year.  Women who did not work the previous year were significantly 
associated with nonadherence among non-Hispanic women but not among Hispanic 
women.  Also, lack of insurance was significantly associated with nonadherence among 
non-Hispanic white women and Hispanic women but not among non-Hispanic black 
women.                    
Low family income, low educational level, and being unmarried have been shown 
to be associated with lower rates of Pap testing (Hewitt et al., 2004).  In our study, 
unmarried categories were differentiated as widowed or separated, divorced, and never 
married.  Women who were never married were the least likely to adhere to cervical 
cancer screening as compared to the other unmarried categories.  One theory is that some 
women in the never married category may not currently be sexually active, and may 
erroneously believe they are not at risk for cervical cancer.  A recent study found single, 
separated/divorced, and widowed women are more likely to be diagnosed with cervical 
cancer at an advanced stage as compared to married women (Ibrahimi & Pinheiro, 2017).  
This further emphasizes the importance of cervical cancer screening for unmarried 
women.  Non-Hispanic white women and Hispanic women who were never married were 
least likely to be screened, but this was not a significant predictor for non-Hispanic black 
women.            
Systematic reviews have shown a positive association between education and 
cervical cancer screening (Damiani et al., 2015), as well as between health literacy and 
cervical cancer (Kim & Han, 2016).  Educational attainment has been shown to have a 
significant correlation with knowledge of cervical cancer risk factors (Akinlotan et al., 
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2017).  Many studies regarding education, knowledge, and perceptions focus on specific 
ethnic groups.  The most common reason for lack of regular Pap testing is the belief that 
it is not necessary if no symptoms are present (Juon et al., 2003).  College graduates were 
38% more likely to adhere to cervical cancer screening guidelines as compared to a high 
school graduate.  Thus, cervical cancer screening adherence improves with increasing 
education even past a high school degree.  Having a college degree was significantly 
associated with screening adherence among non-Hispanic women but not among 
Hispanic women.           
 Research on the association of chronic conditions and cancer screening has shown 
varied results.  Some studies have found that chronic conditions such as diabetes are a 
barrier to cancer screening, while other studies have found that chronic diseases increase 
the likelihood of cancer screening adherence (Brown et al., 2013; Guo et al., 2015; Liu et 
al., 2014).  Some have theorized that the presence of a chronic condition indicates more 
physician visits, which may increase the likelihood of pursuing other preventive health 
measures.  Here, we found that having a chronic condition such as diabetes had a higher 
association with cervical cancer screening adherence than not having a chronic condition.  
One could speculate that having a chronic condition may mean more doctors’ visits, 
which may provide more opportunities for recommending preventive screenings.  
Physician recommendation for a Pap test is significantly associated with adherence to 
cervical cancer screening.  Women who did not have a Pap test recommended were 46% 
less likely to adhere to screening guidelines.  Even specialists should stay up-to-date on 
preventive care guidelines to ensure they can provide guidance to their patients, even if 
the visit is for other reasons. 
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 This study supports the importance of health behaviors and knowledge in 
adhering to cervical cancer screening guidelines.  Women who had heard of HPV and 
who had an HPV vaccine were more likely to get cervical cancer screening.  The number 
of office visits in the last 12 months had a positive association with cervical cancer 
screening.  Doctor recommendation also influenced more women to get cervical cancer 
screening.  Women who use birth control or have had a flu shot in the last 12 months 
were more likely to get screened for cervical cancer.  All of these findings show that 
visiting a doctor improves the likelihood of cervical cancer screening.  In addition, 
behaviors indicative of preventive health may make women more likely to pursue cancer 
screening as well. 
Women who are current drinkers were more likely to adhere to cervical cancer 
screening as compared to lifetime abstainers; whereas women who are current smokers 
were less likely to adhere to cervical cancer screening as compared to never smokers.  A 
previous cross-sectional study using the Behavioral Risk Factor Surveillance System also 
found that the odds of current smokers having had a Pap test in the last 3 years was 0.70 
as compared to never smokers (MacLaughlan, Lachance, & Gjelsvik, 2011).  With 
smoking being a risk factor for cervical cancer, current smokers should be targeted for 
interventions to increase their adherence to pap testing and consequently diagnosis at an 
earlier stage of the disease.  
The limitations of this study included self-reported data, which may not 
accurately capture cervical cancer screening adherence as a result of recall bias, social 
desirability, and over-reporting of Pap test utilization.  Women may also erroneously 
believe their pelvic exam included a Pap test.   
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Enhanced education about the importance of cervical cancer screening and 
targeted interventions are needed for women aged under 30 and over 40 years, unmarried, 
unemployed, uninsured women, women with less education, women with no usual source 
of care, and current smokers.   
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Table 1.1:  Percentage of women with cervical cancer screening adherence by selected characteristics - National Health 
Interview Survey, United States, 2015 (N=10,667)   
     Variables Total Sample % % Adherent 
(weighted) 
Crude OR (95% CI) 
     Total 10,667 
   Weighted 75,830,736 
 
81.7 
 
     Demographics 
    Age 
    21-29 years 2286 21.4 76.0 1.00 
30-39 years 2745 25.7 86.7 2.06*** (1.69, 2.51) 
40-49 years 2255 21.1 83.2 1.56*** (1.26, 1.93) 
50-65 years 3381 31.7 80.9 1.34** (1.12, 1.59) 
 
    Race/Ethnicity 
    Non-Hispanic white 6068 56.9 83.4 1.00 
Hispanic 2140 20.1 77.8 0.70*** (0.59, 0.82) 
Non-Hispanic black 1601 15.0 84.2 1.06 (0.88, 1.28) 
Asian 704 6.6 72.6 0.53*** (0.42, 0.67) 
Other  154 1.4 73.1 0.54* (0.33, 0.89) 
  
 
 
 Marital Status 
    Married 4936 46.4 85.5 1.00 
Widowed or Separated 812 7.6 79.0 0.64** (0.49, 0.84) 
Divorced 1661 15.6 81.3 0.74** (0.60, 0.91) 
Never married 3234 30.4 74.5 0.50*** (0.43, 0.58) 
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Highest level of school completed 
    Less than high school 1238 11.6 69.3 0.72*** (0.58, 0.90) 
High school graduate or GED 2184 20.5 75.8 1.00 
Some college or associate degree 3496 32.9 81.6 1.42*** (1.17, 1.72) 
College graduate 3720 35.0 88.2 2.39*** (1.97, 2.90) 
  
 
 
 Employed last year 
    Yes 7865 73.8 84.5 1.00 
No 2795 26.2 73.7 0.51*** (0.45, 0.59) 
  
 
 
 Acculturation 
    Geographic region of birth 
    United States 8348 78.3 83.3 1.00 
Mexico, C. America, Caribbean, S. America 1392 13.1 77.9 0.70*** (0.58, 0.85) 
Europe, Russia 182 1.7 78.0 0.71 (0.46, 1.09) 
Africa 113 1.1 70.0 0.47** (0.28, 0.77) 
Middle East, Asia 568 5.3 71.1 0.49*** (0.39, 0.63) 
Elsewhere 56 0.5 76.4 0.65 (0.28, 1.48) 
 
    How well is English spoken 
    Very well, well 9838 92.2 82.5 1.00 
Not well, not at all 829 7.8 69.6 0.48*** (0.40, 0.59) 
 
    Period of U.S. Residence 
  U.S. born 8348 78.5 83.3 1.00 
In U.S. ≥ 10 years 1818 17.1 78.3 0.72*** (0.61, 0.85) 
In U.S. < 10 years 475 4.5 65.1 0.37*** (0.30, 0.47) 
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Access to Care and Utilization  
 
 
 Health care coverage 
    Private 6751 64.7 85.6 1.00 
Medicaid and other public 1859 17.8 78.2 0.60*** (0.51, 0.71) 
Other coverage 478 4.6 84.0 0.89 (0.64, 1.23) 
Uninsured 1340 12.9 64.0 0.30*** (0.25, 0.36) 
  
 
 
 Outpatient clinic visits - past 12 months 
    None 1587 14.9 56.5 0.32*** (0.26, 0.40) 
1 1838 17.3 80.0 1.00 
2-3 3018 28.3 86.1 1.55*** (1.26, 1.92) 
4+ 4209 39.5 88.1 1.85*** (1.53, 2.24) 
 
    Usual source of care 
  Has usual source 9157 86.4 84.4 1.00 
None or hospital emergency department 1441 13.6 64.9 0.34*** (0.29, 0.41) 
 
    Chronic Conditions 
    No 5735 54.5 80.3 1.00 
Yes 4779 45.5 83.4 1.23** (1.07, 1.42) 
 
  
  Health Behaviors and Knowledge 
    Body Mass Index 
    <18.5 226 2.1 69.4 0.50*** (0.34, 0.75) 
18.5-24.9 3913 37.2 81.9 1.00 
25-29.9 2724 25.9 82.5 1.05 (0.88, 1.24) 
>=30 3666 34.8 81.5 0.98 (0.83, 1.15) 
  
 
 
 Ever heard of HPV 
    Yes 7854 75.5 85.9 1.00 
No 2552 24.5 69.0 0.35*** (0.31, 0.41) 
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    Ever received HPV shot/vaccine 
    Yes 1173 11.6 89.5 1.00 
No 8972 88.4 80.8 0.50*** (0.38, 0.64) 
  
 
 
 Age when first child born 
    Never gave birth 3189 30.1 74.8 1.00 
<21 years 2472 23.4 80.5 1.39*** (1.16, 1.65) 
21-29 years 3644 34.4 85.8 2.03*** (1.72, 2.38) 
>=30 years 1274 12.0 89.7 2.92*** (2.27, 3.75) 
     Doctor recommended pap test 
    Yes 5566 53.3 89.3 1.00 
No 4392 42.1 78.5 0.44*** (0.38, 0.51) 
Did not see a doctor in the past 12 months 479 4.6 54.7 0.15*** (0.11, 0.19) 
     Currently taking birth control pills, 
implants, or shots 
    Yes 1877 17.8 91.3 1.00 
No 8676 82.2 79.7 0.37*** (0.30, 0.47) 
     Alcohol drinking status 
    Lifetime abstainer 2315 21.8 71.5 1.00 
Former drinker 1278 12.0 78.6 1.46*** (1.18, 1.82) 
Current drinker 7017 66.1 85.5 2.35*** (2.00, 2.75) 
 
    Smoking status 
    Never smoker 7222 67.8 82.1 1.00 
Former smoker 1719 16.1 86.0 1.34** (1.12, 1.60) 
Current smoker 1713 16.1 74.9 0.65*** (0.54, 0.78) 
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Flu shot past 12 months 
    Yes 4310 40.5 88.5 1.00 
No 6341 59.5 76.9 0.43*** (0.38, 0.50) 
     Risk of breast cancer compared to average 
women 
    More likely 1178 11.7 85.7 1.00 
Less likely, about as likely 8888 88.3 81.5 0.74** (0.59, 0.92) 
     Reported health status 
    Excellent, very good, or good 9421 88.3 82.4 1.00 
Fair or poor 1245 11.7 75.3 0.65*** (0.54, 0.79) 
 
  
  *<0.05, **<0.01, ***<0.001 
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Table 1.2:  Adjusted odds ratios of cervical cancer screening adherence by race - National Health Interview Survey, United States, 2015 
     Variables Overall Non-Hispanic White Non-Hispanic Black Hispanic 
     Total  8,898 4,582 1,219 1,501 
     Demographics 
    Age 
    21-29 years 1.00 1.00 1.00 1.00 
30-39 years 1.59*** (1.30, 1.94) 1.71** (1.16, 2.53) 1.33 (0.70, 2.50) 1.50* (1.01, 2.23) 
40-49 years 1.24 (1.00, 1.54) 0.87 (0.59, 1.29) 1.11 (0.56, 2.22) 1.40 (0.87, 2.25) 
50-65 years 0.96 (0.78, 1.19) 0.80 (0.56, 1.14) 1.04 (0.52, 2.07) 1.26 (0.71, 2.23) 
 
    Race/Ethnicity     
Non-Hispanic white 1.00 - - - 
Hispanic 1.47** (1.16, 1.86) - - - 
Non-Hispanic black 2.26*** (1.83, 2.80) - - - 
Asian 1.16 (0.75, 1.78) - - - 
Other 1.11 (0.67, 1.84) - - - 
     
Marital Status 
    Married 1.00 1.00 1.00 1.00 
Widowed or Separated 0.90 (0.71, 1.15) 0.91 (0.60, 1.38) 0.90 (0.45, 1.81) 1.09 (0.54, 2.22) 
Divorced 0.94 (0.77, 1.14) 0.97 (0.68, 1.39) 0.46 (0.21, 1.01) 1.58 (0.87, 2.89) 
Never married 0.67*** (0.56, 0.79) 0.48*** (0.35, 0.68) 0.95 (0.53, 1.72) 0.60** (0.41, 0.87) 
 
    Highest level of school completed 
    Less than high school 1.04 (0.83, 1.29) 0.82 (0.49, 1.37) 0.69 (0.40, 1.19) 0.75 (0.48, 1.16) 
High school graduate or GED 1.00 1.00 1.00 1.00 
Some college or associate degree 1.11 (0.94, 1.32) 1.02 (0.73, 1.43) 1.58 (0.96, 2.63) 0.96 (0.64, 1.45) 
College graduate 1.38*** (1.14, 1.67) 1.61** (1.13, 2.30) 2.46** (1.34, 4.51) 1.33 (0.66, 2.66) 
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Work last year 
    Yes 1.00 1.00 1.00 1.00 
No 0.65*** (0.56, 0.75) 0.64** (0.48, 0.84) 0.52** (0.33, 0.81) 0.74 (0.50, 1.10) 
 
    Acculturation 
    Geographic region of birth 
    United States 1.00 1.00 1.00 1.00 
Mexico, Central America, Caribbean, South America 1.24 (0.94, 1.64) - 0.67 (0.29, 1.56) 1.22 (0.79, 1.89) 
Europe, Russia 0.72 (0.46, 1.14) 0.56* (0.34, 0.92) 3.02 (0.19, 47.01) 0.24* (0.06, 0.95) 
Africa 0.58 (0.31, 1.06) 0.76 (0.12, 4.89) 0.87 (0.37, 2.07) - 
Middle East, Asia 0.62* (0.38, 0.99) 0.47 (0.17, 1.35) - - 
Elsewhere 1.27 (0.55, 2.93) 0.80 (0.23, 2.78) 0.21 (0.03, 1.77) - 
 
    Access to Care and Utilization 
    Health care coverage 
    Private 1.00 1.00 1.00 1.00 
Medicaid and other public 0.94 (0.77, 1.14) 0.93 (0.65, 1.34) 0.85 (0.52, 1.42) 0.84 (0.54, 1.30) 
Other coverage 0.96 (0.71, 1.29) 1.40 (0.85, 2.31) 1.20 (0.55, 2.64) 1.24 (0.54, 2.83) 
Uninsured 0.72* (0.59, 0.88) 0.66* (0.45, 0.97) 0.55 (0.28, 1.12) 0.59* (0.37, 0.94) 
 
    Outpatient clinic visits - past 12 months 
    None 0.54** (0.45, 0.66) 0.52** (0.34, 0.79) 0.50* (0.26, 0.96) 0.46*** (0.30, 0.71) 
1 1.00 1.00 1.00 1.00 
2-3 1.38*** (1.14, 1.67) 1.41 (1.00, 1.99) 1.90 (0.96, 3.75) 1.06 (0.67, 1.70) 
4+ 1.74*** (1.44, 2.09) 1.66** (1.21, 2.29) 1.75 (0.99, 3.09) 1.62* (1.02, 2.58) 
 
    Usual source of care 
    Has usual source 1.00 1.00 1.00 1.00 
None or hospital emergency department 0.68*** (0.57, 0.81) 0.64** (0.47, 0.87) 1.10 (0.59, 2.06) 0.98 (0.63, 1.53) 
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Health Behaviors and Knowledge 
    Ever heard of HPV 
    Yes 1.00 1.00 1.00 1.00 
No 0.56*** (0.49, 0.65) 0.58*** (0.44, 0.76) 0.40*** (0.26, 0.62) 0.54*** (0.38, 0.75) 
 
    Ever received HPV shot/vaccine 
    Yes 1.00 1.00 1.00 1.00 
No 0.64*** (0.50, 0.83) 0.56* (0.35, 0.88) 0.88 (0.46, 1.70) 0.43** (0.25, 0.76) 
 
    Age when first child born 
    Never gave birth 1.00 1.00 1.00 1.00 
<21 years 2.20*** (1.81, 2.67) 1.85** (1.29, 2.65) 2.94*** (1.73, 5.01) 3.54*** (2.17, 5.76) 
21-29 years 2.02*** (1.70, 2.40) 1.61** (1.18, 2.20) 1.83* (1.02, 3.27) 3.76*** (2.46, 5.74) 
>=30 years 2.56*** (2.00, 3.34) 1.77** (1.16, 2.69) 2.64* (1.05, 6.64) 5.21*** (2.23, 12.17) 
     Doctor recommended pap test 
    Yes 1.00 1.00 1.00 1.00 
No 0.54*** (0.47, 0.61) 0.66*** (0.52, 0.84) 0.42*** (0.27, 0.67) 0.50*** (0.34, 0.72) 
Did not see a doctor in the past 12 months 0.38*** (0.29, 0.49) 0.51* (0.29, 0.88) 0.27** (0.10, 0.72) 0.47* (0.24, 0.91) 
     Currently taking birth control pills, implants, or 
shots 
    Yes 1.00 1.00 1.00 1.00 
No 0.47*** (0.38, 0.59) 0.50*** (0.35, 0.70) 0.46* (0.23, 0.90) 0.67* (0.46, 0.97) 
     Alcohol drinking status 
    Lifetime abstainer 1.00 1.00 1.00 1.00 
Former drinker 1.10 (0.89, 1.37) 1.00 (0.69, 1.46) 1.12 (0.56, 2.26) 1.00 (0.52, 1.90) 
Current drinker 1.50* (1.27, 1.76) 1.61** (1.16, 2.23) 0.96 (0.59, 1.57) 1.48 (0.99, 2.20) 
 
    Smoking status 
    Never smoker 1.00 1.00 1.00 1.00 
Former smoker 1.00 (0.82, 1.211) 1.00 (0.74, 1.34) 1.97 (0.89, 4.35) 0.85 (0.41, 1.75) 
Current smoker 0.70* (0.59, 0.84) 0.70* (0.51, 0.96) 0.97 (0.54, 1.74) 0.98 (0.59, 1.61) 
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Flu shot past 12m 
    Yes 1.00 1.00 1.00 1.00 
No 0.66*** (0.57, 0.76) 0.65*** (0.51, 0.84) 0.57** (0.38, 0.85) 0.65* (0.42, 0.99) 
     Reported health status 
    Excellent, very good, or good 1.00 1.00 1.00 1.00 
Fair or poor 0.72** (0.59, 0.88) 0.67* (0.48, 0.96) 0.71 (0.37, 1.35) 1.35 (0.89, 2.07) 
 
*<0.05, **<0.01, ***<0.001 
 
    1. There were 1,769 records that could not be used in the analysis due to missing values (24 for missing marital status, 29 for missing education, 7 for 
missing work status, 8 for missing region of birth, 239 for missing insurance status, 15 for missing number of office visits, 69 for missing usual 
source of care, 261 for missing HPV knowledge, 522 for receipt of HPV vaccine, 88 for missing maternal age, 230 for missing physician 
recommendation, 114 for missing birth control use, 57 for missing alcohol use, 13 for missing smoking status, and 16 for missing flu shot). 
2. The odds ratios were adjusted for all the factors. 
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CHAPTER V. 
MANUSCRIPT 2 
Association of marital status with cervical cancer screening among women aged 21 
to 65 years in the United States, 2015 National Health Interview Survey 
 
Abstract 
Background:  Despite evidence that adherence to screening guidelines decreases 
mortality, women are still dying from a preventable disease due to underutilization of 
screening.  Studies have found that unmarried women are more likely to have a delayed-
stage cervical cancer diagnosis as compared to married women, suggesting 
underutilization of cervical cancer screening among unmarried women.  The primary aim 
of this study was to examine cervical cancer screening adherence in the United States 
among unmarried women, including women who were divorced, separated, widowed, or 
never married.  Methods:  The 2015 National Health Interview Survey data were used to 
explore cervical cancer screening adherence behavior in 10,643 women between the ages 
of 21 and 65 years.  Cervical cancer screening adherence was defined as having a Pap test 
in the last three years, or co-testing with a Pap test and HPV test in the last five years.  
Previously married and never married women were combined to create a variable for a 
sample of 5,707 unmarried women.  Logistic regression was used, and demographics, 
acculturation, access to care and utilization, chronic condition, and health behavior and 
knowledge variables were studied by race.  Results:  Among unmarried women, 78.6% were 
adherent.  Women aged 30 to 39 years of age had the highest odds of screening adherence 
(aOR 2.38, CI 1.71-3.31).  Women who were not employed last year (aOR 0.48, CI 0.38-
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0.62), had no physician office visits (aOR 0.58, CI 0.40-0.85), did not have a usual source 
of care (aOR 0.67, CI 0.50-0.89), had never heard of HPV (aOR 0.59, CI 0.46-0.76), had 
never received an HPV shot (aOR 0.50, CI 0.34-0.75), were not currently taking birth 
control pills (aOR 0.33, CI 0.23-0.47), did not get a flu shot in the past 12 months (aOR 
0.62, CI 0.48-0.80), and perceived their risk of breast cancer as less likely or about as 
likely as the average women (aOR 0.66, CI 0.47-0.92) had a lower odds of screening 
adherence, regardless of race.  Conclusion:  Unmarried women had lower rates of 
cervical cancer screening adherence as compared to married women.  Targeted 
interventions are needed to increase screening among unmarried women, particularly 
those who are not employed and do not pursue preventive measures such as physician 
office visits and flu shots. 
 
Background 
 In 2015, there were approximately 257,524 women with cervical cancer in the 
United States.  In 2018, there are 13,240 estimated new cases of cervical cancer, which is 
0.8% of all new cancer cases.  There are 4,170 estimated deaths, which represents 0.7% 
of all cancer deaths.  Among women with cervical cancer, 66.2% survive five years after 
being diagnosed (NCI, 2018). 
 The United States Preventive Services Task Force recommends cervical cancer 
screening for women ages 21 to 65 years old.  Appropriate screening methods are a 
Papanicolaou (Pap) smear every 3 years or, for women 30 years of age or older, a Pap 
smear and human papillomavirus (HPV) co-test every five years (USPSTF, 2016).  
Despite evidence that adherence to screening guidelines decreases mortality, women are 
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still developing invasive cervical cancer and dying from a rather preventable disease due 
to underutilization of screening (Benard et al., 2014).  Approximately 81% of United 
States women are up-to-date on cervical cancer screening, which is short of the Healthy 
People 2020 goal of 93% (Watson et al., 2017; ODPHP, 2018).  Therefore, it continues to 
be important to identify factors associated with cervical cancer screening adherence. 
Marital status has been identified as a factor associated with cervical cancer 
screening (Chen et al., 2012).  Moreover, studies have found that being unmarried is a 
predictor of delayed-stage cervical cancer diagnosis (Politi et al., 2008; Saghari et al., 
2015).  This suggests underutilization of cervical cancer screening among unmarried 
women, which can lead to a greater risk for adverse health outcomes.  In 2016, there were 
over 61 million unmarried adult women in the United States, which includes women who 
were widowed, divorced, separated, or never married (Census Bureau, 2017).  There is 
limited evidence on the effect of marital status on cervical cancer screening adherence 
among United States women.  In addition, black and Hispanic women have the highest 
age-adjusted mortality attributed to cervical cancer in the United States (Saghari et al., 
2015).  The primary aim of this study was to examine cervical cancer screening 
adherence in the United States among married and unmarried women, including women 
who were divorced, separated, widowed, or never married.  Unmarried women were also 
stratified by race to better understand screening behaviors.   
 
Methods 
 We used the 2015 National Health Interview Survey (NHIS) for this study 
(National Center for Health Statistics, CDC, 2017).  The NHIS is a cross-sectional 
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household interview survey with a multistage area probability design that allows for 
representative sampling of household and non-institutional group quarters.  The sampling 
plan was a sample of clusters of addresses in primary sampling units, which consist of a 
county, small group of contiguous counties, or a metropolitan statistical area (CDC, 
2018). 
 The NHIS questionnaire had core and supplemental questions.  The core 
questionnaire consisted of household, family, sample adult, and sample child 
components.  The supplemental questions included topics such as Healthy People 
objectives, cancer screening, complementary and alternative medicine, children’s mental 
health, and healthcare utilization (CDC, 2018).  The 2015 person, sample adult, and 
cancer files were merged together.     
 The sample for this study consisted of women who were between the ages of 21 
and 65.  Women who had a hysterectomy or a history of cervical cancer were excluded.  
The outcome variable was cervical cancer screening adherence.  Cervical cancer 
screening adherence was defined as having had at least one Pap test during the last 3 
years, or for those 30-65 as having had a Pap test and HPV test during the last 5 years.  
Screening adherence was assessed by the following questions: “When did you have your 
most recent pap test?”  “Did you have an HPV test with your most recent pap?” 
 Demographic, acculturation, access to care and utilization, chronic conditions, 
and health behaviors and knowledge variables were explored as predictors for Pap test 
adherence among unmarried women.  Demographic variables included age, 
race/ethnicity, marital status, education level, and employment status.  Marital status 
included the following categories:  married, widowed, separated, divorced, and never 
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married.  Women who reported themselves as widowed, separated, or divorced were 
considered to be previously married in this study.  Previously married and never married 
women were then combined to create a variable for unmarried women. 
Acculturation was assessed using the geographic region of birth, English 
proficiency, and period of U.S. residence variables.  Access to care variables included 
insurance type, office visits in past 12 months, and usual source of care.  A chronic 
condition variable combined hypertension, high cholesterol, congestive heart failure, 
heart disease, emphysema, chronic obstructive pulmonary disease, asthma, cancer, or 
diabetes.  Health behaviors and knowledge included BMI level, ever heard of HPV, ever 
received HPV vaccine, age when first child born, doctor recommended pap test, birth 
control use, alcohol drinking status, smoking status, flu shot, risk perception of breast 
cancer, and reported health status.   
Descriptive analyses were first performed.  Then, a multiple logistic regression 
model was used to examine the relationship between selected variables and cervical 
cancer screening adherence among married and unmarried women, and analysis was then 
stratified by race to determine significant predictors among unmarried women.  
Backward elimination and stepwise procedures were used for the selection of variables 
into the model.  Multicollinearity was tested for to ensure predictors were not highly 
correlated.  SAS 7.12 was used to perform the analysis.  All analyses included statistical 
weights to account for the complex survey design, oversampling, post-stratification, and 
survey nonresponse.  Weight, stratum, and cluster variables were used to specify the 
sample design.  SAS Proc SURVEY and its statements were used to allow for correct 
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estimation from a complex sample.  This study was determined to be non human subjects 
research due to the use of publically available de-identified data. 
 
Results 
 The sample consisted of 10,643 women between the ages of 21 and 65 without a 
hysterectomy or history of cancer and who reported their marital status.  Table 2.1 shows 
the distribution of characteristics by marital status among women who adhered to cervical 
cancer screening guidelines.  The highest percentage of married (32.1%) and previously 
married (49.8%) women were 50 to 65 years old; whereas the highest percentage of never 
married women was 21 to 29 years old (43.2%).  The majority of women had completed 
some college (29.5% of married women, 36.3% previously married, 35.5% never 
married) or were college graduates (40.4% of married women, 27.3% previously married, 
32.5% never married).  More women were employed in the year prior to the study (71.5% 
of married women, 73.3% previously married, 77.7% never married) as compared to 
those who were not employed (28.5% of married women, 26.7% previously married, 
22.3% never married).   
The majority of women spoke English very well or well (90.3% of married 
women, 93.7% previously married, 94.1% never married) and were born in the United 
States (73.8% of married women, 80.7% previously married, 83.8% never married).  
Women with private insurance (74.1% of married women, 56.7% previously married, 
56.5% never married), four or more office visits (38.5% of married women, 43.3% 
previously married, 38.2% never married), and a usual source of care (88.6% of married 
women, 88.1% previously married, 81.7% never married) had the highest percentages 
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across all marital statuses.  A greater proportion of women did not have chronic 
conditions among married (56.0%) and never married women (60.6%).  For previously 
married women, a greater proportion had a chronic condition (56.4%).   
A higher proportion of women were obese among previously married (38.4%) and 
unmarried women (37.2%); whereas women with normal body mass index represented 
the highest proportion among married women (39.9%).  Women who had heard of HPV, 
had not received an HPV shot, had a doctor recommend a Pap test, were not currently 
taking birth control pills, were current drinkers, were never smokers, had a flu shot in the 
past 12 months, perceived themselves as less likely at risk for breast cancer, and had an 
excellent or good self-reported health status represented the majority of respondents with 
cervical cancer screening adherence across all marital statuses.  There was a greater 
proportion of married (43.6%) and previously married (38.7%) women with their age at 
the birth of their first child being 21 to 29 years, whereas never married women had a 
higher proportion if they never gave birth (58.8%).       
Women who were previously married or never married were combined for a total 
of 5,707 unmarried women, representing 33,400,724 women in the United States (Table 
2.2).  There were 4,936 married women, representing 42,328,266 women.  We performed 
a multivariable analysis to calculate the odds ratios for cervical cancer screening 
adherence, adjusting for other variables.  Age, employment status, number of physician 
office visits in the past 12 months, usual source of care, HPV knowledge, receipt of HPV 
vaccine, age when first child was born, birth control use, alcohol drinking status, smoking 
status, receipt of flu shot in past 12 months, risk perception of breast cancer, and reported 
health status were significant predictors of cervical cancer screening adherence among 
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unmarried women.  Among those variables, age, employment status, receipt of HPV 
vaccine, risk perception of breast cancer, and reported health status were not significant 
in married women.  Unmarried women with all races combined and aged 30 to 39 years 
had the highest odds of screening adherence (aOR 2.38, CI 1.171-3.31), whereas 
Hispanic women aged 40 to 49 years had the highest odds (aOR 2.44, CI 1.24-4.80) 
(Table 2.3).  Unmarried women who were not employed last year (aOR 0.48, CI 0.38-
0.62), had no physician office visits (aOR 0.58, CI 0.40-0.85), and did not have a usual 
source of care (aOR 0.67, CI 0.50-0.89) had a lower odds of screening adherence, 
regardless of race.      
Among health behavior and knowledge variables, unmarried women who had 
never heard of HPV (aOR 0.59, CI 0.46-0.76), had never received an HPV shot (aOR 
0.50, CI 0.34-0.75), were not currently taking birth control pills (aOR 0.33, CI 0.23, 
0.47), did not get a flu shot in the past 12 months (aOR 0.62, CI 0.48, 0.80), and 
perceived their risk of breast cancer as less likely or about as likely as the average women 
(aOR 0.66, CI 0.47-0.92) had lower odds of cervical cancer screening adherence, 
regardless of race.  Unmarried women overall (aOR 3.72, CI 2.13-6.49) and unmarried 
non-Hispanic white women (aOR 3.11, CI 1.64-5.90) who were over 30 years of age had 
the highest odds of screening adherence as compared to unmarried women who never 
gave birth, whereas unmarried Hispanic women who were 21 to 29 years of age had the 
highest odds (aOR 6.37, CI 3.53-11.48).  Unmarried women overall (aOR 1.90, CI 1.43-
2.51) and non-Hispanic white women (aOR 2.58, CI 1.69, 3.95) who were current 
drinkers had the highest odds of screening adherence as compared to lifetime abstainers.  
Unmarried women overall (aOR 0.65, CI 0.48-0.89) and non-Hispanic white women 
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(aOR 0.52, CI 0.33-0.79) who reported fair or poor health status had lower odds of 
screening adherence as compared to women who reported excellent or good health status. 
 
Discussion 
 We assessed predictors for cervical cancer screening among married and 
unmarried women in the United States.  To our knowledge, there are few studies with a 
similar sample of unmarried women in the United States to compare our results.  Overall, 
52% of women in this study were unmarried, and 79% of unmarried women adhered to 
cervical cancer screening guidelines.  Our finding of 79% cervical cancer screening 
adherence among unmarried women was consistent with a study using the Behavioral 
Risk Factor Surveillance System Survey (Hanske et al., 2016).  The proportion of 
unmarried women adhering to screening guidelines has been shown to be lower when 
compared to women of all marital status (83%) (White et al., 2017).   
 Failure to adhere to cervical cancer screening guidelines has been shown to be the 
primary reason for late-stage diagnosis of cervical cancer (Saghari et al., 2015).  It has 
been suggested that marital status affects the diagnosis and prognosis to cancer.  Married 
women were more likely to be diagnosed at an early stage of cervical cancer as compared 
to unmarried women (El-Haddad et al., 2015).  Single/divorced/widowed and never 
married women as compared to married women were shown to have the strongest 
predictors of delayed-stage cervical cancer (Saghari et al., 2015).  This suggests that 
married women are more likely to adhere to screening guidelines as compared to other 
marital groups.  Marriage has also been linked to increased survival among cancer 
patients (El-Haddad et al., 2015).  Marital status has been shown to predict survival 
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outcome in other cancers, with married patients having a better survival outcome as 
compared to unmarried patients.  Married women may have increased social support, 
healthier behaviors, and higher income, which in turn may improve outcomes related to 
cancer therapies and rehabilitation (Wang et al., 2017).  Increased financial resources 
may also lead to reliable transportation (Baine et al., 2011). 
Our analysis showed that married, previously married and unmarried women 
differ with regard to age, race/ethnicity, education level, employment level, geographic 
region of birth, English language proficiency, period of United States residency, health 
care coverage, number of physician office visits, having a usual source of care, having a 
chronic condition, body mass index, HPV knowledge, receipt of HPV vaccination, age 
when first child was born, birth control use, alcohol drinking status, smoking status, 
receipt of flu shot in past 12 months, and reported health status.  
 Unmarried women aged 30 to 39 years of age had the highest odds of screening 
adherence (aOR 2.38, CI 1.171-3.31), similar to that of women in all marital statuses 
combined.  The strongest predictor was the age the first child was born.  One theory 
could be that, without the social support of a spouse, older maternal age may bring more 
independence and maturity to make better decisions such as visiting a doctor’s office than 
a younger maternal age.  In addition, being pregnant leads to the possibility of more 
doctor office visits, particularly with a specialist where cervical cancer screening is 
conducted (Hellquist, Czene, Hjalm, Nystrom, & Jonsson, 2014; Merrill, Fugal, Novilla, 
& Raphael, 2005). 
 Previous studies have found employed women are more likely to adhere to 
cervical cancer screening as compared to unemployed women (Clark et al., 2009).  
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Unmarried women may be more likely to depend on their employment for financial 
stability; whereas married women may receive some financial support from their spouse.  
Unmarried women may benefit from physicians who have evening and weekend 
appointments for screening (Clark et al., 2009). 
 The effect of marriage on cervical cancer screening adherence could be explained 
by spouses monitoring each other’s health and promoting healthy behaviors.  Married 
couples may feel responsible for each other’s health, leading to encouragement of a 
healthy lifestyle (El-Haddad et al., 2015).  Marriage may influence healthy behaviors, 
including diet, exercise, and health screenings (Baine et al., 2011).  All of these factors 
are known to promote health.  Married couples also have better social support, which 
improves feelings of happiness, acceptance, and self-efficacy (Baine et al., 2011).  
Emotional support has been found to increase cancer screening adherence (El-Haddad et 
al., 2015).   
 When unmarried women were stratified by race, similar patterns were found for 
each group as were found for the overall unmarried group.  Women who were employed, 
had more than two office visits, and had a usual source of care had higher odds of 
adhering to screening.  Hispanic women with more than four office visits had three times 
higher odds of adhering to cervical cancer screening as compared to only one office visit.  
More office visits may provide more opportunities for patient education.    
Limitations of this study included self-reported data, which may not accurately 
capture cervical cancer screening adherence as a result of recall bias, social desirability, 
and over-reporting of Pap test utilization.  Women may also erroneously believe their 
pelvic exam included a Pap test.  In addition, the NHIS survey is administered to people 
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with landline telephones.  Therefore, the results of this study may be generalizable only 
to women with a landline telephone.  Results from an NHIS survey suggested an 
increasing trend with Americans who only have wireless telephones (Blumberg & Lake, 
2017).   
Public health interventions targeting unmarried women are needed to promote 
cervical cancer screening.  Future studies should explore opportunities, such as physician 
recommendations, to introduce unmarried women to the benefits of adhering to screening 
recommendation.   
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Table 2.1:  Characteristics of women by marital status - National Health Interview Survey, United States, 2015 
(N=10,643) 
     Variables Married Previously Married Never Married P-Value 
Total 4,936 2,473 3,234 
 Weighted 42,328,266 12,944,074 20,456,650 
 Adherence (weighted %) 85.5 80.6 74.5 
     
Demographics 
    Age 
    21-29 years 686 (13.9%) 123 (5.0%) 1486 (45.6%) <0.0001 
30-39 years 1415 (28.7%) 449 (18.2%) 875 (27.1%)  
40-49 years 1216 (24.6%) 595 (24.1%) 439 (13.6%)  
50-65 years 1619 (32.8%) 1306 (52.8%) 444 (13.7%)  
 
    Race/Ethnicity 
    Non-Hispanic white 3126 (63.3%) 1445 (58.4%) 1483 (45.9%) <0.0001 
Hispanic 988 (20.0%) 461 (18.6%) 688 (21.3%)  
Non-Hispanic black 336 (6.8%) 437 (17.7%) 823 (25.4%)  
Asian 436 (8.8%) 91 (3.7%) 175 (5.4%)  
Other 50 (1.0%) 39 (1.6%) 65 (2.0%)  
     
Highest level of school completed 
    Less than high school 549 (11.1%) 330 (13.4%) 356 (11.0%) <0.0001 
High school graduate or GED 931 (18.9%) 567 (23.0%) 679 (21.0%)  
Some college or associate degree 1454 (29.5%) 894 (36.3%) 1144 (35.5%)  
College graduate 1990 (40.4%) 674 (27.3%) 1048 (32.5%)  
     
Employed last year 
    Yes 3258 (71.5%) 1812 (73.3%) 2511 (77.7%) <0.0001 
No 1405 (28.5%) 660 (26.7%) 721 (22.3%)  
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Acculturation 
    Geographic region of birth 
    United States 3631 (73.6%) 1994 (80.6%) 2704 (83.7%) <0.0001 
Mexico, Central America, Caribbean, South America 711 (14.4%) 324 (13.1%) 355 (11.0%)  
Europe, Russia 99 (2.0%) 46 (1.9%) 37 (1.1%)  
Africa 56 (1.1%) 29 (1.2%) 26 (0.8%)  
Middle East, Asia 399 (8.1%) 71 (2.9%) 98 (3.0%)  
Elsewhere 35 (0.7%) 9 (0.4%) 12 (0.4%)  
 
    How well is English spoken 
    Very well, well 4457 (90.3%) 2318 (93.7%) 3042 (94.1%) 0.0012 
Not well, not at all 479 (9.7%) 155 (6.3%) 192 (5.9%)  
 
    Period of U.S. Residence 
U.S. born 3631 (73.8%) 1994 (80.7%) 2704 (83.8%) <0.0001 
In U.S. ≥ 10 years 993 (20.2%) 419 (16.9%) 403 (12.5%)  
In U.S. < 10 years 295 (6.0%) 59 (2.4%) 120 (3.7%)  
     
Access to Care and Utilization 
   
 
Health care coverage 
    Private 3585 (74.1%) 1346 (56.7%) 1808 (56.5%) <0.0001 
Medicaid and other public 459 (9.5%) 551 (23.2%) 846 (26.5%)  
Other coverage 249 (5.1%) 145 (6.1%) 81 (2.5%)  
Uninsured 543 (11.2%) 331 (13.9%) 463 (14.5%)  
     
Outpatient clinic visits - past 12 months 
    None 688 (14.0%) 351 (14.2%) 544 (16.8%) 0.0006 
1 902 (18.3%) 376 (15.2%) 557 (17.2%)  
2-3 1442 (39.2%) 672 (27.2%) 896 (27.7%)  
4+ 1899 (38.5%) 1069 (43.3%) 1232 (38.2%)  
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Usual source of care     
Has usual source 4344 (88.6%) 2168 (88.1%) 2623 (81.7%) <0.0001 
None or hospital emergency department 558 (11.4%) 292 (11.9%) 589 (18.3%)  
 
    Chronic Conditions 
    No 2727 (56.0%) 1056 (43.6%) 1938 (60.6%) <0.0001 
Yes 2144 (44.0%) 1368 (56.4%) 1258 (39.4%)  
 
    
Health Behaviors and Knowledge 
    Body Mass Index 
    <18.5 93 (1.9%) 48 (2.0%) 85 (2.7%) <0.0001 
18.5-24.9 1945 (39.9%) 820 (33.6%) 1139 (35.7%)  
25-29.9 1297 (26.6%) 637 (26.1%) 779 (24.4%)  
>=30 1538 (31.6%) 937 (38.4%) 1187 (37.2%)  
     
Ever heard of HPV 
    Yes 3670 (76.2%) 1693 (71.5%) 2474 (77.4%) <0.0001 
No 1149 (23.8%) 674 (28.5%) 724 (22.6%)  
 
    Ever received HPV shot/vaccine 
    Yes 337 (7.2%) 109 (4.7%) 726 (23.3%) <0.0001 
No 4360 (92.8%) 2204 (95.3%) 2386 (76.7%)  
     
Age when first child born 
    Never gave birth 896 (18.3%) 399 (16.3%) 1890 (58.8%) <0.0001 
<21 years 1003 (20.5%) 796 (32.6%) 667 (20.7%)  
21-29 years 2133 (43.6%) 945 (38.7%) 557 (17.3%)  
>=30 years 864 (17.6%) 304 (12.4%) 102 (3.2%)  
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Doctor recommended pap test 
    Yes 2647 (54.6%) 1318 (54.8%) 1592 (50.4%) 0.2218 
No 1984 (40.9%) 979 (40.7) 1415 (44.8%)  
Did not see a doctor in the past 12 months 215 (4.4%) 109 (4.5%) 154 (4.9%)  
     Currently taking birth control pills, implants, or shots 
    Yes 743 (15.2%) 240 (9.9%) 889 (27.7%) <0.0001 
No 4147 (84.8%) 2194 (90.1%) 2316 (72.3%)  
     Alcohol drinking status 
    Lifetime abstainer 1199 (24.4%) 463 (18.8%) 648 (20.1%) <0.0001 
Former drinker 559 (11.4%) 422 (17.2%) 293 (9.1%)  
Current drinker 3151 (64.2%) 1574 (64.0%) 2278 (70.8%)  
 
    Smoking status 
    Never smoker 3581 (72.6%) 1356 (55.0%) 2270 (70.3%) <0.0001 
Former smoker 832 (16.9%) 490 (19.9%) 390 (12.1%)  
Current smoker 521 (10.6%) 620 (25.1%) 570 (17.6%)  
     Flu shot past 12 months 
    Yes 2146 (43.5%) 1035 (41.9%) 1121 (34.7%) <0.0001 
No 2786 (56.5%) 1434 (58.1%) 2105 (65.3%)  
     Risk of breast cancer compared to average women 
    More likely 529 (11.4%) 311 (13.4%) 337 (11.0%) 0.5782 
Less likely, about as likely 4122 (88.6%) 2004 (86.6%) 2740 (89.0%)  
     Reported health status 
    Excellent, very good, or good 4527 (91.7%) 2025 (81.9%) 2847 (88.1%) <0.0001 
Fair or poor 409 (8.3%) 448 (18.1%) 386 (11.9%)   
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Table 2.2:  Adjusted model of cervical cancer screening adherence by marital status - National Health Interview Survey, 
United States, 2015 
   Variables Married Unmarried 
   Total cervical cancer screening adherence 3,684 3,999 
Weighted 32,168,699 23,020,201 
Adherence (weighted %) 85.5% 78.6% 
   Demographics 
  Age 
  21-29 years 1.00 1.00 
30-39 years 1.12 (0.74, 1.69) 2.38*** (1.71, 3.31) 
40-49 years 0.73 (0.48, 1.13) 2.08*** (1.48, 2.92) 
50-65 years 0.80 (0.53, 1.21) 1.59** (1.13, 2.24) 
 
 
 
Race/Ethnicity 
 
 
Non-Hispanic white 1.00 1.00 
Hispanic 1.08 (0.78, 1.48) 0.95 (0.69, 1.31) 
Non-Hispanic black 1.40 (0.87, 2.25) 1.74*** (1.28, 2.36) 
Asian 0.62* (0.42, 0.90) 0.85 (0.54, 1.35) 
Other 0.62 (0.16, 2.49) 0.95 (0.35, 2.55) 
 
  Employed last year 
  Yes 1.00 1.00 
No 0.80 (0.62, 1.03) 0.48*** (0.38, 0.62) 
 
 
 
 
 
  
91 
 
Access to Care and Utilization 
  Office visits - past 12 months 
  None 0.33*** (0.23, 0.48) 0.58** (0.40, 0.85) 
1 1.00 1.00 
2-3 1.40* (1.01, 1.93) 1.53* (1.06, 2.22) 
4+ 1.92*** (1.37, 2.70) 1.76** (1.26, 2.47) 
 
  Usual source of care 
  Has usual source 1.00 1.00 
None or hospital emergency department 0.58** (0.42, 0.81) 0.67** (0.50, 0.89) 
 
  Health Behaviors and Knowledge 
  Ever heard of HPV 
  Yes 1.00 1.00 
No 0.43*** (0.33, 0.55) 0.59*** (0.46, 0.76) 
 
  Ever received HPV shot/vaccine 
  Yes 1.00 1.00 
No 0.69 (0.38, 1.26) 0.50*** (0.34, 0.75) 
 
  Age when first child born 
  Never gave birth 1.00 1.00 
<21 years 1.04 (0.72, 1.49) 3.10*** (2.43, 3.95) 
21-29 years 1.22 (0.89, 1.68) 2.71*** (2.06, 3.58) 
>=30 years 1.64* (1.09, 2.46) 3.72*** (2.13, 6.49) 
   Currently taking birth control pills, implants, 
or shots 
  Yes 1.00 1.00 
No 0.60** (0.42, 0.86) 0.33*** (0.23, 0.47) 
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Alcohol drinking status 
  Lifetime abstainer 1.00 1.00 
Former drinker 0.93 (0.63, 1.39) 1.06 (0.74, 1.52) 
Current drinker 1.37* (1.02, 1.86) 1.90*** (1.43, 2.51) 
 
  Smoking status 
  Never smoker 1.00 1.00 
Former smoker 0.93 (0.66, 1.3) 1.01 (0.73, 1.40) 
Current smoker 0.42*** (0.29, 0.61) 0.75 (0.56, 1.00) 
   Flu shot past 12 months 
  Yes 1.00 1.00 
No 0.63*** (0.49, 0.81) 0.62*** (0.48, 0.80) 
   Risk of breast cancer compared to average 
women 
  More likely 1.00 1.00 
Less likely, about as likely 1.14 (0.80, 1.61) 0.66* (0.47, 0.92) 
 
 
 
Reported health status 
  Excellent, very good, or good 1.00 1.00 
Fair or poor 0.82 (0.53, 1.26) 0.65** (0.48, 0.89) 
   *<0.05, **<0.01, ***<0.001 
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Table 2.3:  Adjusted model of cervical cancer screening adherence by race among unmarried women - National Health Interview 
Survey, United States, 2015 
     Variables Overall Non-Hispanic White Non-Hispanic Black Hispanic 
     Total  3,999 2,087 1,055 759 
Weighted 23,020,201 13,132,995 5,523,866 3,797,076 
Adherence (weighted %) 78.6 77.9 83.8 77.5 
  
  
  Demographics 
    Age 
    21-29 years 1.00 1.00 1.00 1.00 
30-39 years 2.38*** (1.71, 3.31) 2.61** (1.46, 4.65) 1.54 (0.74, 3.19) 1.79* (1.08, 2.96) 
40-49 years 2.08*** (1.48, 2.92) 1.73* (1.05, 2.84) 1.30 (0.71, 2.40) 2.44* (1.24, 4.80) 
50-65 years 1.59** (1.13, 2.24) 1.33 (0.82, 2.15) 0.94 (0.49, 1.77) 1.69 (0.92, 3.11) 
 
    Employed last year 
    Yes 1.00 1.00 1.00 1.00 
No 0.48*** (0.38, 0.62) 0.47*** (0.32, 0.69) 0.43*** (0.27, 0.69) 0.45*** (0.28, 0.71) 
 
    Access to Care and Utilization 
    Outpatient clinic visits - past 12 months 
    None 0.58** (0.40, 0.85) 0.64 (0.36, 1.14) 0.39** (0.19, 0.79) 0.85 (0.47, 1.54) 
1 1.00 1.00 1.00 1.00 
2-3 1.53* (1.06, 2.22) 1.87** (1.08, 3.23) 1.49 (0.75, 2.96) 1.38 (0.78, 2.45) 
4+ 1.76** (1.26, 2.47) 1.72** (1.04, 2.83) 1.21 (0.67, 2.16) 2.95*** (1.64, 5.30) 
 
    Usual source of care 
    Has usual source 1.00 1.00 1.00 1.00 
None or hospital emergency department 0.67** (0.50, 0.89) 0.52** (0.35, 0.77) 0.80 (0.48, 1.35) 0.74 (0.42, 1.28) 
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Health Behaviors and Knowledge 
    Ever heard of HPV 
    Yes 1.00 1.00 1.00 1.00 
No 0.59*** (0.46, 0.76) 0.65* (0.46, 0.93) 0.37*** (0.24, 0.58) 0.55* (0.33, 0.91) 
 
    Ever received HPV shot/vaccine 
    Yes 1.00 1.00 1.00 1.00 
No 0.50*** (0.34, 0.75) 0.51* (0.29, 0.92) 0.72 (0.37, 1.42) 0.41** (0.24, 0.70) 
 
    Age when first child born 
    Never gave birth 1.00 1.00 1.00 1.00 
<21 years 3.10*** (2.43, 3.95) 2.42*** (1.67, 3.52) 2.32*** (1.49, 3.63) 6.24*** (3.67, 10.60) 
21-29 years 2.71*** (2.06, 3.58) 2.79*** (1.82, 4.28) 1.43 (0.83, 2.48) 6.37*** (3.53, 11.48) 
>=30 years 3.72*** (2.13, 6.49) 3.11*** (1.64, 5.90) 2.61 (0.96, 7.07) 14.88*** (4.42, 50.12) 
     Currently taking birth control pills,  
implants, or shots 
    Yes 1.00 1.00 1.00 1.00 
No 0.33*** (0.23, 0.47) 0.31*** (0.20, 0.49) 0.40* (0.17, 0.94) 0.36*** (0.23, 0.57) 
     Alcohol drinking status 
    Lifetime abstainer 1.00 1.00 1.00 1.00 
Former drinker 1.06 (0.74, 1.52) 1.33 (0.80, 2.21) 0.74 (0.38, 1.43) 0.68 (0.35, 1.34) 
Current drinker 1.90*** (1.43, 2.51) 2.58*** (1.69, 3.95) 1.10 (0.68, 1.78) 1.50 (0.91, 2.47) 
 
    Smoking status 
    Never smoker 1.00 1.00 1.00 1.00 
Former smoker 1.01 (0.73, 1.40) 1.07 (0.72, 1.58) 1.07 (0.59, 1.92) 0.59 (0.20, 1.68) 
Current smoker 0.75 (0.56, 1.00) 0.88 (0.61, 1.28) 0.91 (0.55, 1.49) 0.91 (0.51, 1.63) 
     Flu shot past 12 months 
    Yes 1.00 1.00 1.00 1.00 
No 0.62*** (0.48, 0.80) 0.65* (0.46, 0.91) 0.64 (0.41, 1.02) 0.55* (0.32, 0.93) 
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Risk of breast cancer compared to  
average women 
    More likely 1.00 1.00 1.00 1.00 
Less likely, about as likely 0.66* (0.47, 0.92) 0.66* (0.45, 0.98) 0.63 (0.30, 1.31) 0.37** (0.18, 0.78) 
        
Reported health status 
    Excellent, very good, or good 1.00 1.00 1.00 1.00 
Fair or poor 0.65** (0.48, 0.89) 0.52** (0.33, 0.79) 0.80 (0.49, 1.31) 1.54 (0.80, 2.98) 
     *<0.05, **<0.01, ***<0.001 
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CHAPTER VI. 
MANUSCRIPT 3 
Physician recommendation and patient adherence to cervical cancer screening 
among women aged 21 to 65 years in the United States, 2015 National Health 
Interview Survey 
 
Abstract 
Background:  Physician recommendation has been shown to be a significant predictor of 
cancer screening.  Few studies have investigated differences in patients who receive 
physician recommendation for cervical cancer screening versus those who adhere to 
physician recommendations.  The current study explores the gap between physician 
recommendation and patient adherence in a nationally representative sample of women in 
the United States.  Our objective is to determine the proportion of women who received a 
physician recommendation and proportion of those women who adhered to the physician 
recommendation.  Methods:  The data source for this study was the 2015 National Health 
Interview Survey (NHIS).  The sample for this study consisted of women who were 
between the ages of 21 and 65 who received a physician recommendation for cervical 
cancer screening.  The two outcome variables were receiving a physician 
recommendation and adherence to the physician recommendation for cervical cancer 
screening.  Demographic, acculturation, access to care and utilization, chronic conditions, 
and health behaviors and knowledge variables were explored as predictors for receiving a 
physician recommendation and adherence to the physician recommendation for cervical 
cancer screening.  A multiple logistic regression model was used to examine the 
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relationship between select variables and women who received a physician 
recommendation, and then between the same selected variables and adherence to 
physician recommendation for cervical cancer screening.  Results:  Overall, 56% of 
women with a current physician, reported that cervical cancer screening was 
recommended to them in the past 12 months.  For all respondents, race/ethnicity, health 
care coverage, outpatient clinic visits, usual source of care, HPV knowledge, receiving an 
HPV shot, age when first child born, and receiving a flu shot were significant predictors 
of which respondents received a recommendation for cervical cancer screening.  
Variables that were significant predictors of adherence to physician recommendation for 
screening were education level, employment status, English proficiency, outpatient clinic 
visits, usual source of care, age when first child born, birth control use, alcohol use, 
smoking status, flu shot, and reported health status.  Conclusion:  This study suggests that 
a strategy to further increase cervical cancer screening rates nationally is for physicians to 
recommend screening to all patients who might benefit.  Physician recommendation plays 
an important role in adherence to cervical cancer screening.   
 
Background 
 There are an estimated 13,240 new cases of invasive cervical cancer and 4,170 
deaths occurring in 2018 (ACS, 2018).  Incidence rates of invasive cervical cancer 
declined from 1975 (14.8 per 100,000) to 2014 (6.9 per 100,000), mainly due to 
screening.  The decline has slowed recently, with the overall incidence from 2005 to 2014 
being stable.  Similarly, the pace of reduction for mortality rate has slowed, with a 
decrease of 0.8% per year from 2006 to 2015.  The 5-year survival rate for cervical 
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cancer is 92% when the cancer is diagnosed in a localized stage, but it falls to 57% and 
17% when diagnosed in regional and distant-stage, respectively (ACS, 2018).   
 Physician recommendation has been shown to be a significant predictor of cancer 
screening.  Conversely, the lack of physician recommendation is reported as a reason 
why patients did not adhere to screening guidelines for cancers, such as colorectal cancer 
(Coughlin et al., 2005; Hudson et al., 2012; Jibara, Jandorf, Fodera,&  DuHamel, 2011; 
Shokar, Nguyen-Oghalai, & Wu, 2009; D. Wallace, Baltrus, T. Wallace, Blumenthal, & 
Rust, 2013; ). 
 While physician recommendation has been studied with colorectal cancer and 
breast cancer, few studies have investigated differences in patients who receive physician 
recommendation for cervical cancer screening versus those who adhere to physician 
recommendations.  The current study explores the gap between physician 
recommendation and patient adherence in a nationally representative sample of women in 
the United States.  Our objective is to determine the proportion of women who received a 
physician recommendation and proportion of those women who adhered to the physician 
recommendation.  This will identify patient populations that could benefit from physician 
recommendations and further attention to cervical cancer screening, which could increase 
the number of women who adhere to screening guidelines.  For those who did not follow 
their physician’s recommendation, we explored the reasons for not obtaining a Pap test. 
 
Methods 
 The data source for this study was the 2015 National Health Interview Survey 
(NHIS) (National Center for Health Statistics, CDC, 2017).  The NHIS is a cross-
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sectional household interview survey with a multistage area probability design that 
allows for representative sampling of household and non-institutional group quarters.  
The sampling plan is a sample of clusters of addresses in primary sampling units, which 
consist of a county, small group of contiguous counties, or a metropolitan statistical area 
(CDC, 2018). 
 The NHIS questionnaire had a core set supplemental sets of questions.  The core 
questionnaire consisted of Household, Family, Sample Adult, and Sample Child 
components.  The supplemental questions included topics such as Healthy People 
objectives, cancer screening, complementary and alternative medicine, children’s mental 
health, and healthcare utilization (CDC, 2018).  The 2015 Person, Sample Adult, and 
Cancer files were merged together to create one dataset.  The sample for this study 
consisted of women who were between the ages of 21 and 65 who self-reported receiving 
a physician recommendation for cervical cancer screening.  Women who had a 
hysterectomy or a history of cervical cancer were excluded.  The two outcome variables 
were:  receiving a physician recommendation and adherence to the physician 
recommendation for cervical cancer screening.  Cervical cancer screening adherence was 
defined by having had at least one Pap test during the last 3 years, or for those 30-65 by 
having had a Pap test and HPV test during the last 5 years.  Screening adherence was 
assessed by the following question: “When did you have your most recent pap test?”  
“Did you have an HPV test with your most recent pap?” 
 Demographic, acculturation, access to care and utilization, chronic conditions, 
and health behaviors and knowledge variables were explored as predictors for Pap test 
adherence among unmarried women.  Demographic variables included age, 
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race/ethnicity, marital status, education level, and employment status.  Acculturation was 
assessed using the geographic region of birth, English proficiency, and period of U.S. 
residence variables.   
Access to care variables included insurance type, office visits in past 12 months, 
and usual source of care.  A chronic condition variable combined had hypertension, high 
cholesterol, congestive heart failure, heart disease, emphysema, chronic obstructive 
pulmonary disease, asthma, cancer, or diabetes.  Health behaviors and knowledge 
included BMI level, ever heard of HPV, ever received HPV vaccine, age when first child 
born, doctor recommended pap test, birth control use, alcohol drinking status, smoking 
status, flu shot, risk perception of breast cancer, and reported health status.   
A multiple logistic regression model was used to examine the relationship first 
between selected variables and women who received a physician recommendation, and 
then between the same selected variables and adherence to physician recommendation for 
cervical cancer screening.  Backward elimination and stepwise procedures were used for 
the selection of variables into the model.  Multicollinearity was tested for to ensure 
predictors were not highly correlated.  SAS 7.12 was used to perform the analysis.  All 
analyses included statistical weights to account for the complex survey design, 
oversampling, post-stratification, and survey nonresponse.  Weight, stratum, and cluster 
variables were used to specify the sample design.  SAS Proc SURVEY and its statements 
were used to allow for correct estimation from a complex sample.  This study was 
determined to be non human subjects research due to the use of publically available de-
identified data. 
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Results 
Overall, 56% of women, who self-reported having a current physician, had 
cervical cancer screening recommended to them in the past 12 months.  Younger age 
(P=0.0022), being married (P=0.0001), being employed last year (P=0.0294), having 
private health insurance (P<0.0001), having an outpatient clinic visit (P<0.0001), having 
a usual source of care (P<0.0001), having no chronic conditions (P<0.0001), heard of 
HPV (P<0.0001), having received an HPV vaccine dose (P=0.0397), never given birth 
(P<0.0001), lifetime abstainer of alcohol (P=0.0087), flu shot (P<0.0001), and reporting 
excellent or good health status (P=0.0083) were significant predictors of receiving a 
physician recommendation for cervical cancer screening (Table 3.1). 
Among patients who self-reported receiving a recommendation for cervical 
cancer screening, predictors included younger age (P=0.0002), being married (P=0.0002), 
higher education (P<0.0001), being employed last year (P<0.0001), having private health 
insurance (P<0.0001), having an outpatient clinic visit (P<0.0001), having a usual source 
of care (P<0.0001), heard of HPV (P<0.0001), having received an HPV vaccine 
(P=0.0063), never given birth (P<0.0001), using birth control (P<0.0001), lifetime 
abstainer of alcohol (P<0.0001), never smoker (P<0.0001), flu shot (P<0.0001), and 
reporting excellent or good health status (P<0.0001) (Table 1).  Race/ethnicity, 
geographic region of birth, period of residence in the United States, chronic conditions, 
body mass index, and breast cancer risk perception did not affect whether patients 
adhered to cervical cancer screening recommendations. 
Table 3.2 shows the adjusted odds ratios of receipt of physician recommendation 
for cervical cancer screening and adherence to the physician recommendation.  For all 
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respondents, race/ethnicity, health care coverage, outpatient clinic visits, usual source of 
care, HPV knowledge, receiving an HPV shot, age when first child was born, and 
receiving a flu shot were significant predictors of which respondents received a 
recommendation for cervical cancer screening.  The odds of receiving a recommendation 
were greater for women having four or more outpatient clinic visits (aOR 1.28, CI 1.11-
1.48) and being older than 30 years when the first child was born (aOR 1.85, CI 1.52-
2.24), as compared to one office visit and never giving birth, respectively.  Respondents 
who were Hispanic (aOR 0.73, CI 0.59-0.90), not having a usual source of care (aOR 
0.75, CI 0.62-0.92), having never heard of HPV (aOR 0.83, CI 0.72-0.95), having never 
received an HPV shot (aOR 0.76, CI 0.63-0.91), and not having had a flu shot in the past 
12 months (aOR 0.83, CI 0.74-0.94) had lower odds of receiving a recommendation.  
Age, marital status, employment status, chronic conditions, alcohol use, and reporting 
excellent or good health status were no longer significant predictors of receipt of 
physician recommendations in multivariable analysis. 
Variables that were significant predictors of adherence to physician 
recommendation for screening were education level, employment status, English 
proficiency, outpatient clinic visits, usual source of care, age when first child born, birth 
control use, alcohol use, smoking status, flu shot, and reported health status.  The odds of 
adhering to physician recommendations were greater for women who were college 
graduates (aOR 1.51, CI 1.03-2.21), having four or more outpatient clinic visits (aOR 
1.85, CI 1.26-2.70), being older than 30 years when first child born (aOR 2.87, CI 1.86-
4.41), and being current drinkers (aOR 2.87, CI 1.86-4.41).  Respondents who were not 
employed last year (aOR 0.63, CI 0.46-0.87), not having had a usual source of care (aOR 
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0.64, CI 0.44-0.93), not taking birth control pills (aOR 0.51, CI 0.31-0.83), current 
smokers (aOR 0.53, CI 0.38-0.73), not having had a flu shot in the past 12 months (aOR 
0.52, CI 0.39-0.70), and reporting fair or poor health status (aOR 0.68, CI 0.47-0.99) had 
lower odds of adhering to physician recommendations. 
Among women who received a physician recommendation for cervical cancer 
screening, 392 women provided a reason for why they have not been screened.  The most 
common reasons included:  “Didn’t need it or didn’t know I needed it” (14.0%, CI 10.3-
17.7), no problems (8.7%, CI 6.0-11.5), put it off (11.2%, CI 8.9-13.5), too expensive or 
no insurance (18.8%, CI 13.4-24.2), too painful or embarrassing (5.5%, CI 3.0-8.1), no 
reason/never thought about it (34.0%, CI 29.1-38.8) or other (7.8%, CI 5.1-10.5) (Table 
3). 
 
Discussion 
 We found no difference in receipt of physician recommendation and adherence by 
race ethnicity, but Hispanic ethnicity was associated with lower odds of receiving a 
physician recommendation.  While non-Hispanic black women had lower odds of 
receiving a physician recommendation as compared to non-Hispanic white women, they 
had higher odds of adhering to physician recommendations.  This study also found that 
higher education and being employed increases the odds of adhering to physician 
recommendations for screening. 
Women who were born in Mexico, Central America, Caribbean, and South 
America had the highest odds of receiving a physician recommendation.  The physician-
patient relationship and subsequent communication regarding cancer screening is 
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important for patients with language and cultural barriers (Coughlin et al., 2005; Juon et 
al., 2003; Nguyen et al., 2002).  Previous studies have shown that physician 
recommendation for a Pap test is an important predictor of screening in Hispanic women 
(Ngueyn et al., 2002; O’Malley et al., 2001).   
Insurance type was important for physician recommendation but not in adherence 
to the recommendation.  Education level, employment status, and English proficiency 
only played roles in adhering to physician recommendation but not in receiving physician 
recommendation.  Physicians may be less likely to recommend cancer screening if the 
patient does not have insurance or is unable to otherwise pay for services (Wallace et al., 
2013). 
The number of outpatient clinic visits significantly increased the odds of receiving 
a physician recommendation and the odds of adhering to the recommendation.  Women 
with co-morbidities may visit their doctor more frequently, which would then be 
consistent with studies that have reported patients with co-morbidities were more likely 
to receive recommendations for cancer screening (Wallace et al., 2013). 
 Among reasons reported by women who did not adhere to cervical cancer 
screening after a physician recommends it, some stated they did not know they needed it.  
Some women believe that Pap tests are for women who are younger, sexually active, or 
pregnant.  This may lead them to think that routine screenings are not relevant to them.  
Communications regarding sexual behavior during a clinic visit have been shown to 
improve cancer screening rates (Politi et al., 2008). 
Evidence has shown patient-provider communication to be a predictor of cancer 
screening among women (Politi et al., 2008).  Positive communications can lead to 
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changes in health behavior, adherence to medical advice, increased understanding about 
the importance of screening, and higher satisfaction with care.  This may result in 
increased cancer screening rates (Politi et al., 2008). 
The main limitations of this study is self-reported data, which may not accurately 
capture cervical cancer screening adherence as a result of recall bias, social desirability, 
and over-reporting of Pap test utilization.  Women may also erroneously believe their 
pelvic exam included a Pap test, or they may not realize they had a Pap test during their 
pelvic exam.  In addition, women may not recall whether their physician provided a 
recommendation.  Self-report does not allow us to explore physician barriers to 
understand why physicians may have been more likely to recommend or not recommend 
screening. 
This study suggests the physician recommendations may increase cervical cancer 
screening rates.  A strategy to further increase cervical cancer screening rates nationally 
is for physicians to recommend screening to all patients who might benefit.  Physician 
recommendation plays an important role in adherence to cervical cancer screening.  In 
addition, strategies to address the reasons for non-adherence to cervical cancer screening 
are needed.  One such strategy could be sensitivity training for physicians on delivering 
cervical cancer screening recommendations and on performing the tests.  In addition to 
recommending cervical cancer screening, physicians should consider communication 
about sexual health to address any misconceptions about the risk of cervical cancer. 
Comprehensive communication that includes cervical cancer screening 
recommendations and sexual health may have a positive impact on screening adherence.  
Future research should consider optimal approaches for communication with women to 
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promote cervical cancer screening.  Moreover, the type of physician, such as primary care 
or gynecologist, providing the recommendation should be examined.  In addition, 
adherence to recommendations received from physicians should be compared to those 
received from physician extenders, such as nurse practitioners.  Some office visits do not 
include face-to-face interactions with physicians, and instead a physician extender may 
be the one to conduct the visit. 
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Table 3.1: Receipt of and adherence to physician recommendation for cervical cancer screening - National Health 
Interview Survey, United States, 2015 (N=9,958)   
  
         Variables Received Physician Recommendation Adherence to Physician Recommendation 
 
         Overall 5,566 
   
4,944 
   Weighted 39,610,272 
   
35,367,305 
            
Demographics Total Sample % 
% Recommended  
(weighted) P-Value Total Sample % 
% Adherence  
(weighted) P-Value 
Age 
        21-29 years 1132 20.3 52.1 0.0022 1029 20.8 90.5 0.0002 
30-39 years 1422 25.5 54.7  1298 26.3 92.6 
 40-49 years 1188 21.3 58.1  1070 21.6 88.8 
 50-65 years 1824 32.8 58.7  1547 31.3 86.3 
  
        Race/Ethnicity 
        Non-Hispanic white 3284 59.0 57.5 0.0536 2898 58.6 89.3 0.4981 
Hispanic 1061 19.1 53.5  951 19.2 88.5 
 Non-Hispanic black 825 14.8 54.0  751 15.2 91.4 
 Asian 327 5.9 54.3  282 5.7 87.8 
 Other 69 1.2 45.8  62 1.3 87.3 
          
   Marital Status 
        Married 2647 47.6 58.0 0.0001 2395 48.5 91.3 0.0002 
Widowed or Separated 420 7.6 55.2 
 
354 7.2 87.0 
 Divorced 898 16.2 58.0 
 
785 15.9 86.2 
 Never married 1592 28.6 51.3 
 
1403 28.4 86.6 
      
   Highest level of school completed 
        Less than high school 619 11.1 56.4 0.7248 507 10.3 79.4 <.0001 
High school graduate or GED 1098 19.8 55.4  933 18.9 85.5 
 Some college or associate degree 1840 33.1 55.3  1642 33.3 90.0 
 College graduate 1996 35.9 57.1  1849 37.5 93.0 
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    Employed last year 
        Yes 4075 73.2 55.2 0.0294 3684 74.5 91.2 <.0001 
No 1489 26.8 58.5  1258 25.5 84.1 
       
   Acculturation 
        Geographic region of birth 
        United States 4425 79.5 56.1 0.9767 3937 79.7 89.8 0.1094 
Mexico, C. America, Caribbean,  
   S. America 
712 12.8 56.5  642 
13.0 
88.6 
 Europe, Russia 96 1.7 54.2  80 1.6 84.8 
 Africa 48 0.9 57.3  44 0.9 89.7 
 Middle East, Asia 256 4.6 54.0  221 4.5 87.3 
 Elsewhere 26 0.5 57.0  18 0.4 70.4 
  
        How well is English spoken 
        Very well, well 5168 92.8 56.1 0.7578 4585 92.7 89.2 0.6699 
Not well, not at all 398 7.2 55.3  359 7.3 90.1 
  
        Period of U.S. Residence 
   U.S. born 4425 79.6 56.1 0.8828 3937 79.7 89.8 0.167 
In U.S. ≥ 10 years 909 16.4 55.4  804 16.3 89.0 
 In U.S. < 10 years 223 4.0 56.9  196 4.0 87.0 
  
 
    
   Access to Care and Utilization 
   
  
   Health care coverage 
        Private 3568 65.5 56.7 <.0001 3263 67.3 91.7 <.0001 
Medicaid and other public 1057 19.4 61.4  923 19.0 86.8 
 Other coverage 249 4.6 50.8  207 4.3 86.4 
 Uninsured 576 10.6 46.6  458 9.4 77.8 
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Outpatient clinic visits –  
past 12 months 
        None 505 9.1 39.8 <.0001 340 6.9 66.7 <.0001 
1 904 16.3 52.6  784 15.9 86.4 
 2-3 1647 29.6 57.8  1504 30.4 92.0 
 4+ 2507 45.1 60.6  2316 46.8 92.6 
  
        Usual source of care 
   Has usual source 5022 90.7 57.8 <.0001 4533 92.1 90.5 <.0001 
None or hospital emergency dept. 515 9.3 42.5  389 7.9 77.8 
  
        Chronic Conditions 
        No 2853 53.9 53.6 <.0001 2543 52.2 89.1 0.7198 
Yes 2638 49.9 59.3  2333 47.8 89.5 
 
 
    
    Health Behaviors and Knowledge 
        Body Mass Index 
        <18.5 101 1.8 45.4 0.0696 85 1.7 85.8 0.5938 
18.5-24.9 2013 36.7 55.0  1792 36.8 89.9 
 25-29.9 1444 26.3 56.5  1282 26.3 89.6 
 >=30 1926 35.1 57.3  1710 35.1 88.5 
       
   Ever heard of HPV 
        Yes 4309 79.0 57.4 <.0001 3906 80.5 90.9 <.0001 
No 1145 21.0 51.1  947 19.5 83.5 
  
        Ever received HPV shot/vaccine 
        Yes 672 12.7 59.6 0.0397 630 13.4 93.3 0.0063 
No 4615 87.3 55.3  4071 86.6 88.8 
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Age when first child born 
Never gave birth 1505 27.2 49.8 <.0001 1298 26.4 86.7 0.0014 
<21 years 1301 23.5 56.9  1136 23.1 87.8 
 21-29 years 1976 35.7 57.9  1781 36.2 90.5 
 >=30 years 755 13.6 63.6  706 14.3 92.7 
 
         Currently taking birth control  
pills, implants, or shots 
        Yes 1075 19.4 58.3 0.1488 1010 20.6 95.1 <.0001 
No 4455 80.6 55.6  3902 79.4 87.9 
 
         Alcohol drinking status 
        Lifetime abstainer 1114 20.1 52.7 0.0087 962 19.5 84.9 <.0001 
Former drinker 709 12.8 59.9  599 12.2 84.6 
 Current drinker 3717 67.1 56.4  3362 68.3 91.4 
  
        Smoking status 
        Never smoker 3743 67.3 55.9 0.9178 3403 68.9 90.8 <.0001 
Former smoker 926 16.7 56.4  828 16.8 91.1 
 Current smoker 890 16.0 56.5  709 14.4 80.2 
 
         Flu shot past 12 months 
        Yes 2477 44.6 60.8 <.0001 2299 46.6 93.4 <.0001 
No 3082 55.4 52.6  2639 53.4 85.9 
 
         Risk of breast cancer compared  
to average women 
        More likely 662 7.0 60.0 0.0794 602 12.7 90.6 0.4164 
Less likely, about as likely 4651 49.2 56.0  4126 87.3 89.2 
 
         Reported health status 
        Excellent, very good, or good 4847 87.1 55.5 0.0083 4346 87.9 90.2 <.0001 
Fair or poor 719 12.9 61.1   598 12.1 82.3 
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Table 3.2: Adjusted odds ratios of receipt of and adherence to physician recommendation for cervical cancer screening - 
National Health Interview Survey, United States, 2015 
   
Variables 
Received Physician 
Recommendation 
Adherence to Physician 
Recommendation 
   Overall 4,797 4,280 
Weighted 42,768,435 36,708,797 
   Demographics Adjusted Odds Ratio Adjusted Odds Ratio 
Race/Ethnicity 
  Non-Hispanic white 1.00 1.00 
Hispanic 0.73** (0.59, 0.90) 1.08 (0.72, 1.64) 
Non-Hispanic black 0.85 (0.71, 1.01) 1.85** (1.23, 2.79) 
Asian 0.98 (0.66, 1.47) 0.93 (0.56, 1.57) 
Other 0.61 (0.33, 1.14) 1.13 (0.37, 3.47) 
     
Highest level of school completed - 
 Less than high school   0.64 (0.40, 1.02) 
High school graduate or GED   1.00 
Some college or associate degree   1.19 (0.84, 1.68) 
College graduate   1.51* (1.03, 2.21) 
 
  Employed last year - 
 Yes   1.00 
No   0.63** (0.46, 0.87) 
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Acculturation 
  Geographic region of birth 
 
- 
United States 1.00 
 Mexico, C. America, Caribbean, S. America 1.46** (1.16, 1.84)   
Europe, Russia 0.91 (0.58, 1.42)   
Africa 1.35 (0.68, 2.68)   
Middle East, Asia 1.01 (0.66, 1.55)   
Elsewhere 1.09 (0.51, 2.34)   
 
  How well is English spoken - 
 Very well, well   1.00 
Not well, not at all   2.36* (1.22, 4.58) 
 
  Access to Care and Utilization 
  Health care coverage 
 
- 
Private 1.00   
Medicaid and other public 1.28** (1.09, 1.49)   
Other coverage 0.76* (0.58, 0.99)   
Uninsured 0.91 (0.74, 1.13)   
   
Outpatient clinic visits - past 12 months 
  None 0.66*** (0.55, 0.80) 0.34*** (0.22, 0.53) 
1 1.00 1.00 
2-3 1.18* (1.01, 1.38) 1.53* (1.06, 2.21) 
4+ 1.28** (1.11, 1.48) 1.85** (1.26, 2.70) 
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Usual source of care 
Has usual source 1.00 1.00 
None or hospital emergency department 0.75** (0.62, 0.92) 0.64* (0.44, 0.93) 
 
  Health Behaviors and Knowledge 
  Ever heard of HPV 
  Yes 1.00 1.00 
No 0.83** (0.72, 0.95) 0.77 (0.57, 1.04) 
 
  Ever received HPV shot/vaccine 
 
- 
Yes 1.00   
No 0.76** (0.63, 0.91)   
   
Age when first child born 
  Never gave birth 1.00 1.00 
<21 years 1.45*** (1.23, 1.71) 2.69*** (1.79, 4.02) 
21-29 years 1.46*** (1.26, 1.68) 2.32*** (1.62, 3.33) 
>=30 years 1.85*** (1.52, 2.24) 2.87*** (1.86, 4.41) 
   Currently taking birth control pills, 
implants, or shots 
  Yes 1.00 1.00 
No 0.93 (0.79, 1.08) 0.51** (0.31, 0.83) 
   Alcohol drinking status - 
 Lifetime abstainer   1.00  
Former drinker   1.01 (0.67, 1.52) 
Current drinker   1.63** (1.15, 2.31) 
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Smoking status - 
 Never smoker    1.00 
Former smoker   1.06 (0.75, 1.50) 
Current smoker   0.53*** (0.38, 0.73) 
   Flu shot past 12 months 
  Yes 1.00 1.00 
No 0.83** (0.74, 0.94) 0.52*** (0.39, 0.70) 
   Reported health status 
  Excellent, very good, or good 1.00 1.00 
Fair or poor 1.19 (0.97, 1.45) 0.68* (0.47, 0.99) 
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Table 3.3:  Reasons why cervical cancer screening not obtained after physician recommendation 
Reasons Frequency Weighted Frequency Sample % 95% Confidence Interval 
No reason/never thought about it 144 898,715 33.97 29.11 38.83 
Didn't need it/didn't know needed it 39 369,787 13.98 10.28 17.68 
No problems 37 230,950 8.73 5.99 11.47 
Put it off 39 296,063 11.19 8.89 13.49 
Too expensive, no insurance 73 498,239 18.83 13.43 24.23 
Too painful, embarrassing 23 145,887 5.51 2.97 8.06 
Other 37 206,079 7.79 5.11 10.47 
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VII. 
CONCLUSION 
 
The purpose of this research was to:  Describe predictors for cervical cancer 
screening adherence using current guidelines among a sample of nationally representative 
women; assess the association of marital status with cervical cancer screening adherence; 
and explore the gap between physician recommendation of cervical cancer screening and 
adherence to physician recommendation.  
The results of this study indicate about 1 in 5 women in the United States are not 
being screened for cervical cancer as recommended.  Furthermore, the results suggest that 
interventions to improve screening should be targeted to women under 30 and over 40 
years of age, unmarried women, women who do not work, uninsured women, women 
with no usual source of care, and current smokers.  
Women who were married had increased odds of adherence with cervical cancer 
screening recommendations compared to women in other marital categories.  The 
findings of this study are important because few studies have explored the effect of 
marital status on cervical cancer screening adherence in the United States. 
 Cervical cancer screening rates for unmarried women are lower than those among 
married women.  Unmarried women would benefit from targeted interventions to 
improve their screening rates.  Physicians, regardless of their specialty, who are 
examining or treating unmarried women should take the opportunity to educate them 
about screening guidelines. 
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A strategy to further increase cervical cancer screening rates nationally is for 
physicians to recommend screening to all patients who might benefit.  Physician 
recommendation plays an important role in adherence to cervical cancer screening.  
While most studies look at lack of adherence to cervical cancer screening after physician 
recommendation, our study examines who does follow their physician recommendations 
for cervical cancer screening.  The results of this study will allow physicians and 
policymakers to target women who are less likely to adhere to cervical cancer screening 
recommendations. 
 
Limitations 
Limitations of this study included self-reported data, which may not accurately 
capture cervical cancer screening adherence as a result of recall bias, social desirability, 
and over-reporting of Pap test utilization.  Women may also erroneously believe their 
pelvic exam included a Pap test.  Also, women who have multiple doctors’ appointments 
may not recall what occurred at each appointment.  Women who know the screening 
recommendations but chose not to adhere may respond favorably to having received a 
recent Pap test, even if they did not have one.  In addition, self-report does not allow us to 
explore physician barriers to understand why physicians may have been more likely to 
recommend or not recommend screening. 
Face-to-face interviews are conducted in respondents’ homes.  Telephone 
interviews are permitted if follow-ups to complete interviews are needed, the respondent 
requests a telephone interview, or when road conditions or travel distances are a barrier to 
to scheduling a visit before the completion date.  NHIS asks respondents to provide 
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residential telephone numbers, to allow recontacting of survey participants.  The NHIS 
survey is administered to people with landline telephones.  Therefore, there may be 
undercoverage due to not being able to reach persons with landline telephones.  Results 
from an NHIS survey suggested an increasing trend with Americans who only have 
wireless telephones.  Even those who have a landline may be difficult to reach due to a 
wireless telephone being their primary mode of communication (Blumberg & Lake, 
2017).   
Missing data was not included in this study.  Missing data can reduce statistical 
power, cause bias in parameter estimations, and can reduce the sample’s 
representativeness.  However, less than 10% was missing from each variable.     
 
Directions for future research 
Despite these limitations, our findings suggest important considerations for 
cervical cancer screening program planning and further research.  Future research should 
review barriers to screening in more detail.  Health promotion programs should consider 
addressing multiple prevention behaviors simultaneously.  For example, our findings 
consistently showed receiving a flu shot to be a significant predictor of cervical cancer 
screening.  Healthcare providers who administer flu shots may have an opportunity to 
educate patients of other preventive behaviors.  
Public health interventions targeting unmarried women are needed to promote 
cervical cancer screening.  Future studies should explore opportunities, such as physician 
recommendations, to introduce unmarried women to the benefits of adhering to screening 
recommendation.    
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Strategies to address the reasons for non-adherence to cervical cancer screening 
are needed, such as sensitivity training for physicians on delivering cervical cancer 
screening recommendations and performing the tests.  In addition, open communications 
about sexual health are needed to address any misconceptions about the risk of cervical 
cancer.  Comprehensive communication that includes cervical cancer screening 
recommendations and sexual health may have a positive impact on screening adherence.  
Positive communications can lead to changes in health behavior, adherence to medical 
advice, increased understanding about the importance of screening, and higher 
satisfaction with care, which can lead to increased cancer screening rates.  Future studies 
should examine various mechanisms for physician recommendations to determine 
feasible and cost-effective ways to increase recommendations and adherence to the 
recommendations. 
 Future research should also consider self-collected HPV testing for women non-
adherent to cervical cancer screening.  Some studies have shown participation of under-
screened women can be improved by offering HPV self-testing at home.  Women have 
expressed positive acceptance due to the elimination of logistical barriers, such as lack of 
time or transportation to a health center, and avoidance of psychological barriers, such as 
embarrassment and stress of undergoing cervical cancer screening (Katz, Zimmermann, 
Moore, Paskett, & Reiter, 2016; Mao et al., 2017).  While it can only be used for testing 
by clinically validated assays and not cytological analyses, offering self-sampling devices 
to non-adherent women can increase screening participation (Mistro et al., 2017).  Home 
HPV screening tests may be more widely accepted by both patients and physicians if it 
does not impact access to a physician to address other health concerns (Mao et al., 2017).   
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